SV_chrom,CytoBand,Gene_name,ACMG_class,GenCC_disease,GenCC_moi,GenCC_classification,Caller,Gene_topology
1,p22.1,ABCA4,full=5,cone-rod dystrophy 3;severe early-childhood-onset retinal dystrophy,AR,Definitive,Delly,5'UTR-3'UTR
1,p31.1,ACADM,full=5,medium chain acyl-CoA dehydrogenase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,ADAMTSL4,full=5,"ectopia lentis 2, isolated, autosomal recessive;ectopia lentis et pupillae",AR,Strong,Delly,5'UTR-3'UTR
1,q21.3,ADAR,full=5,Aicardi-Goutieres syndrome 6;Leigh syndrome;dyschromatosis symmetrica hereditaria,AD;AR,Definitive;Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q24.2,ADCY10,full=5,"hypercalciuria, absorptive, 2",AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p21.2,AGL,full=5,glycogen storage disease III,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.33,AGRN,full=5,congenital myasthenic syndrome 8,AR,Strong,Delly,5'UTR-3'UTR
1,p36.11-p35.3,AHDC1,full=5,AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p35.1,AK2,full=5,reticular dysgenesis,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.13,ALDH4A1,full=5,hyperprolinemia type 2,AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p21.3,ALG14,full=5,congenital myasthenic syndrome 15,AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,ALG6,full=5,congenital disorder of glycosylation type 1C,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,ALPL,full=5,adult hypophosphatasia;childhood hypophosphatasia;hypophosphatasia;infantile hypophosphatasia,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,ALX3,full=5,frontorhiny,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.2,AMPD1,full=5,myopathy due to myoadenylate deaminase deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p13.3,AMPD2,full=5,pontocerebellar hypoplasia type 9,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,ANGPTL3,full=5,familial hypobetalipoproteinemia 2,AR,Moderate,Delly,5'UTR-3'UTR
1,p13.2,AP4B1,full=5,AP-4 deficiency syndrome;hereditary spastic paraplegia 47,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p22.1,ARHGAP29,full=5,cleft lip with or without cleft palate,AD,Definitive,Delly,5'UTR-3'UTR
1,p36.11,ARID1A,full=5,"Coffin-Siris syndrome;Coffin-Siris syndrome 1;intellectual disability, autosomal dominant 14",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.1,ARL8A,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q22,ASH1L,full=5,"intellectual disability, autosomal dominant 40;intellectual disability, autosomal dominant 52",AD,Strong,Delly,5'UTR-3'UTR
1,q31.3,ASPM,full=5,"microcephaly 5, primary, autosomal recessive",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.33,ATAD3A,full=5,"pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal",AR,Strong,Delly,5'UTR-3'UTR
1,q23.3,ATF6,full=5,achromatopsia;achromatopsia 7,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,ATP13A2,full=5,Kufor-Rakeb syndrome;autosomal recessive spastic paraplegia type 78,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.1,ATP1A1,full=5,"charcot-marie-tooth disease, axonal, type 2DD;hypomagnesemia, seizures, and intellectual disability 2",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q23.2,ATP1A2,full=5,"alternating hemiplegia of childhood 1;familial or sporadic hemiplegic migraine;migraine, familial hemiplegic, 2",AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p36.33,B3GALT6,full=5,"Ehlers-Danlos syndrome, progeroid type, 2;spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,BSND,full=5,Bartter disease type 4a,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,C1QA,full=5,C1Q deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.12,C1QB,full=5,C1Q deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.12,C1QC,full=5,C1Q deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p32.2,C8B,full=5,type II complement component 8 deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,q25.3,CACNA1E,full=5,"developmental and epileptic encephalopathy, 69",AD,Strong,Delly,5'UTR-3'UTR
1,q32.1,CACNA1S,full=5,"congenital myopathy;hypokalemic periodic paralysis, type 1;malignant hyperthermia, susceptibility to, 5",AD;AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.31-p36.23,CAMTA1,full=5,nonprogressive cerebellar atxia with mental retardation,AD,Strong,Delly,5'UTR-3'UTR
1,p13.1,CASQ2,full=5,Hypertrophic cardiomyopathy;catecholaminergic polymorphic ventricular tachycardia;catecholaminergic polymorphic ventricular tachycardia 2,AD;AR,Definitive;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p35.2,CCDC28B,full=5,Bardet-Biedl syndrome 1,AR,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q24.2,CD247,full=5,immunodeficiency 25,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.2,CD46,full=5,atypical hemolytic-uremic syndrome with MCP/CD46 anomaly,AD;sD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p21.2,CDC14A,full=5,autosomal recessive nonsyndromic deafness 105;autosomal recessive nonsyndromic deafness 32;hearing impairment and infertile male syndrome;nonsyndromic genetic deafness,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.12,CDC42,full=5,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,q31.2,CDC73,full=5,hyperparathyroidism-jaw tumor syndrome,AD,Definitive,Delly,5'UTR-3'UTR
1,q41,CENPF,full=5,Stromme syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p36.32,CEP104,full=5,Joubert syndrome 17;Joubert syndrome 25,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q31.3,CFHR5,full=5,C3 glomerulonephritis,AD,Strong,Delly,5'UTR-3'UTR
1,q32.1,CHI3L1,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.3,CHRNB2,full=5,autosomal dominant nocturnal frontal lobe epilepsy 3,AD,Strong,Delly,5'UTR-3'UTR
1,p22.3,CLCA2,full=5,heart conduction disease,AD,Moderate,Delly,5'UTR-3'UTR
1,p36.13,CLCNKA,full=5,Bartter disease type 4B,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.13,CLCNKB,full=5,Bartter disease type 4B,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,CLDN19,full=5,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,COA7,full=5,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p21.1,COL11A1,full=5,Marshall syndrome;Stickler syndrome type 2;fibrochondrogenesis 1,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p22.3,COL24A1,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.2,COL9A2,full=5,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q25.3,COLGALT2,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q23.2,COPA,full=5,autoimmune interstitial lung disease-arthritis syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,p32.3,CPT2,full=5,"Carnitine palmitoyltransferase II deficiency;carnitine palmitoyl transferase II deficiency, myopathic form;carnitine palmitoyl transferase II deficiency, neonatal form;carnitine palmitoyl transferase II deficiency, severe infantile form",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.2,CR2,full=5,"immunodeficiency, common variable, 7",AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,q31.3,CRB1,full=5,Leber congenital amaurosis 8,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.3,CSF3R,full=5,autosomal recessive severe congenital neutropenia due to CSF3R deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p31.1,CTH,full=5,cystathioninuria (disease),AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p34.2,CTPS1,full=5,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p36.21,CTRC,full=5,hereditary chronic pancreatitis,AD,Definitive,Delly,5'UTR-3'UTR
1,q21.3,CTSK,full=5,pycnodysostosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q25.1,DARS2,full=5,leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p21.2,DBT,full=5,maple syrup urine disease;maple syrup urine disease type 2,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.3,DCST1,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.12,DDOST,full=5,DDOST-CDG,AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,q23.3,DDR2,full=5,spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome;warburg-cinotti syndrome,AD;AR,Definitive;Limited;Moderate,Delly,5'UTR-3'UTR
1,q32.1,DDX59,full=5,orofaciodigital syndrome V,AR,Strong,Delly,5'UTR-3'UTR
1,p32.3,DHCR24,full=5,desmosterolosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,DNAJC6,full=5,juvenile onset Parkinson disease 19A,AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p31.3,DOCK7,full=5,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q22,DPM3,full=5,DPM3-CDG,AR,Strong,Delly,5'UTR-3'UTR
1,p13.3,DRAM2,full=5,cone-rod dystrophy 21,AR,Strong,Delly,5'UTR-3'UTR
1,q32.1,DSTYK,full=5,"congenital anomalies of kidney and urinary tract 1, susceptibility to",AD;AR,Definitive;Limited,Delly,5'UTR-3'UTR
1,p36.33,DVL1,full=5,autosomal dominant Robinow syndrome 2,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,ECE1,full=5,"essential hypertension, genetic",NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.2,ECM1,full=5,lipoid proteinosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,EIF2B3,full=5,leukoencephalopathy with vanishing white matter,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ELOVL1,full=5,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.13,EMC1,full=5,"cerebellar atrophy, visual impairment, and psychomotor retardation;",AR,Moderate,Delly,5'UTR-3'UTR
1,p35.3,EPB41,full=5,elliptocytosis 1,AR,Strong,Delly,5'UTR-3'UTR
1,p36.31,ESPN,full=5,autosomal recessive nonsyndromic deafness 36;nonsyndromic genetic deafness,AD;AR,Definitive;Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q31.3,F13B,full=5,"factor XIII, b subunit, deficiency of",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.2,F5,full=5,congenital factor V deficiency;thrombophilia due to activated protein C resistance,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.3,FAM71A,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q24.3,FASLG,full=5,autoimmune lymphoproliferative syndrome type 1,AR,Moderate,Delly,5'UTR-3'UTR
1,q23.3,FCGR2B,full=5,systemic lupus erythematosus (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q22,FDPS,full=5,"porokeratosis 9, multiple types",AD,Strong,Delly,5'UTR-3'UTR
1,q21.3,FLAD1,full=5,myopathy with abnormal lipid metabolism,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.3,FLG,full=5,autosomal dominant ichthyosis vulgaris,AD;AR;sD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q21.3,FLG2,full=5,peeling skin syndrome 6,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.3,FLVCR1,full=5,posterior column ataxia-retinitis pigmentosa syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.3,FMO3,full=5,trimethylaminuria (disease),AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p33,FOXE3,full=5,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.11,FUCA1,full=5,fucosidosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11,GALE,full=5,galactose epimerase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.3,GATAD2B,full=5,severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,q22,GBA,full=5,Gaucher disease;Gaucher disease perinatal lethal;Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;late-onset Parkinson disease,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,GJA5,full=5,"atrial fibrillation, familial, 11;heart conduction disease",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.3,GJB3,full=5,autosomal dominant nonsyndromic deafness 2B;erythrokeratodermia variabilis;erythrokeratodermia variabilis et progressiva 1;nonsyndromic genetic deafness,AD;AR,Disputed Evidence;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.3,GJB4,full=5,erythrokeratodermia variabilis et progressiva 2,AD;AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p22.1,GLMN,full=5,glomuvenous malformation,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q25.3,GLUL,full=5,congenital brain dysgenesis due to glutamine synthetase deficiency,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.3,GNAI3,full=5,auriculocondylar syndrome 1,AD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p13.3,GNAT2,full=5,achromatopsia 4,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.33,GNB1,full=5,"intellectual disability, autosomal dominant 42",AD,Moderate,Delly,5'UTR-3'UTR
1,q24.2,GORAB,full=5,geroderma osteodysplastica,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.3,GPSM2,full=5,Chudley-McCullough syndrome,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.11,GRHL3,full=5,van der Woude syndrome 1;van der Woude syndrome 2,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.22,H6PD,full=5,cortisone reductase deficiency 1,AR,Moderate,Delly,5'UTR-3'UTR
1,q21.3,HAX1,full=5,Kostmann syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p22.2,HFM1,full=5,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Disputed Evidence,Delly,5'UTR-3'UTR
1,q32.2,HHAT,full=5,chondrodysplasia-pseudohermaphroditism syndrome,AR,Moderate,Delly,5'UTR-3'UTR
1,q21.1,HJV,full=5,hemochromatosis type 2A,AR,Strong,Delly,5'UTR-3'UTR
1,p36.11,HMGCL,full=5,3-hydroxy-3-methylglutaric aciduria,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,HMGCS2,full=5,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,HNRNPR,full=5,"intellectual disability, autosomal dominant 40",AD,Definitive,Delly,5'UTR-3'UTR
1,q21.3,HORMAD1,full=5,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Moderate,Delly,5'UTR-3'UTR
1,p35.1,HPCA,full=5,torsion dystonia 2,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,HPDL,full=5,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Delly,5'UTR-3'UTR
1,p12,HSD3B2,full=5,congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p36.12,HSPG2,full=5,Silverman-Handmaker type dyssegmental dysplasia,AR,Definitive,Delly,5'UTR-3'UTR
1,q23.1,INSRR,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q32.2,IRF6,full=5,autosomal dominant popliteal pterygium syndrome;van der Woude syndrome 1,AD,Definitive,Delly,5'UTR-3'UTR
1,p36.33,ISG15,full=5,mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p13.3,KCNA2,full=5,infantile epilepsy syndrome;undetermined early-onset epileptic encephalopathy,AD,Strong,Delly,5'UTR-3'UTR
1,p13.2,KCND3,full=5,Brugada syndrome 1;Brugada syndrome 9;spinocerebellar ataxia type 19/22,AD,Disputed Evidence;Limited;Strong,Delly,5'UTR-3'UTR
1,q32.2,KCNH1,full=5,Temple-Baraitser syndrome;Zimmermann-Laband syndrome 1,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.2,KCNJ10,full=5,EAST syndrome;enlarged vestibular aqueduct syndrome,AD;AR,Definitive;Disputed Evidence;Strong,Delly,5'UTR-3'UTR
1,p34.2,KCNQ4,full=5,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q31.3,KCNT2,full=5,"developmental and epileptic encephalopathy, 57",AD,Moderate,Delly,5'UTR-3'UTR
1,p36.12,KDM1A,full=5,palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q32.1,KDM5B,full=5,Tourette syndrome;autism susceptibility 1,AD,No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,q32.1,KIF14,full=5,lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.12,KIF17,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.22,KIF1B,full=5,"Charcot-Marie-Tooth disease type 2A1;neuroblastoma, susceptibility to;phaeochromocytoma",AD,Limited;Moderate;No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q32.2,LAMB3,full=5,"amelogenesis imperfecta type 1A;junctional epidermolysis bullosa;junctional epidermolysis bullosa Herlitz type;junctional epidermolysis bullosa, non-Herlitz type",AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q25.3,LAMC2,full=5,"junctional epidermolysis bullosa;junctional epidermolysis bullosa Herlitz type;junctional epidermolysis bullosa, non-Herlitz type",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11,LDLRAP1,full=5,"hypercholesterolemia, familial, 4",AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,LEPR,full=5,obesity due to leptin receptor gene deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,q25.2,LHX4,full=5,short stature-pituitary and cerebellar defects-small sella turcica syndrome,AD,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q22,LMNA,full=5,"Charcot-Marie-Tooth disease type 2B1;Emery-Dreifuss muscular dystrophy 2, autosomal dominant;Hutchinson-Gilford progeria syndrome;Primary dilated cardiomyopathy;arrhythmogenic right ventricular cardiomyopathy;atrioventricular block (disease);dilated cardiomyopathy 1A;familial partial lipodystrophy, Dunnigan type;heart-hand syndrome, Slovenian type",AD;AR;sD,Definitive;Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,LMX1A,full=5,autosomal dominant nonsyndromic deafness 7,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,q21.3,LORICRIN,full=5,keratoderma hereditarium mutilans with ichthyosis,AD,Strong,Delly,5'UTR-3'UTR
1,p13.2,LRIG2,full=5,urofacial syndrome 2;urofacial syndrome type 1,AR,Strong,Delly,5'UTR-3'UTR
1,p32.3,LRP8,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.3,MACF1,full=5,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.22,MASP2,full=5,immunodeficiency due to MASP-2 deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p35.3,MECR,full=5,"Leigh syndrome;dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,MFSD2A,full=5,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,MMACHC,full=5,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,MPL,full=5,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,MPZ,full=5,Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease type 1B,AD,Definitive,Delly,5'UTR-3'UTR
1,q22,MSTO1,full=5,mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.22,MTHFR,full=5,homocystinuria due to methylene tetrahydrofolate reductase deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.22,MTOR,full=5,macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q22,MUC1,full=5,medullary cystic kidney disease 1,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.1,MUTYH,full=5,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,q24.3,MYOC,full=5,"glaucoma 1, open angle, A;glaucoma 3A",AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q25.3,NCF2,full=5,"granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.2,NCSTN,full=5,"acne inversa, familial, 1",AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,NDUFS2,full=5,"Leigh syndrome;mitochondrial complex 1 deficiency, nuclear type 6",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.3,NECTIN4,full=5,ectodermal dysplasia-syndactyly syndrome 1,AR,Moderate,Delly,5'UTR-3'UTR
1,p31.1,NEXN,full=5,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;hypertrophic cardiomyopathy 20,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q32.1,NFASC,full=5,neurodevelopmental disorder with central and peripheral motor dysfunction,AD;AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p31.3,NFIA,full=5,chromosome 1p32-p31 deletion syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,p36.22,NMNAT1,full=5,Leber congenital amaurosis 9,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,NOTCH2,full=5,Alagille syndrome;acroosteolysis dominant type,AD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p36.31,NPHP4,full=5,nephronophthisis 4,AR,Definitive,Delly,5'UTR-3'UTR
1,q25.2,NPHS2,full=5,"nephrotic syndrome, type 2",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.22,NPPA,full=5,"Primary dilated cardiomyopathy;atrial fibrillation, familial, 6",AD;AR,Moderate;No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.11,NR0B2,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p13.2,NRAS,full=5,Costello syndrome;Noonan syndrome;Noonan syndrome 6;Noonan syndrome with multiple lentigines;cardiofaciocutaneous syndrome,AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q23.1,NTRK1,full=5,hereditary sensory and autonomic neuropathy type 4,AR,Definitive,Delly,5'UTR-3'UTR
1,p32.3,ORC1,full=5,Meier-Gorlin syndrome 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,P3H1,full=5,osteogenesis imperfecta type 8,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,PADI3,full=5,uncombable hair syndrome 1,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.23,PARK7,full=5,autosomal recessive early-onset Parkinson disease 7,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p32.3,PARS2,full=5,"developmental and epileptic encephalopathy, 75",AR,Moderate,Delly,5'UTR-3'UTR
1,p36.13,PAX7,full=5,"congenital myopathy with myasthenic-like onset;myopathy, congenital, progressive, with scoliosis",AR,Moderate,Delly,5'UTR-3'UTR
1,q23.3,PBX1,full=5,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",AD,Strong,Delly,5'UTR-3'UTR
1,p32.3,PCSK9,full=5,"hypercholesterolemia, autosomal dominant, 3",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.32,PEX10,full=5,peroxisome biogenesis disorder;peroxisome biogenesis disorder 6A (Zellweger);peroxisome biogenesis disorder 6B,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.1,PEX11B,full=5,peroxisome biogenesis disorder;peroxisome biogenesis disorder 14B,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.22,PEX14,full=5,peroxisome biogenesis disorder;peroxisome biogenesis disorder 13A (Zellweger),AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.2,PEX19,full=5,peroxisome biogenesis disorder;peroxisome biogenesis disorder 12A (Zellweger);peroxisome biogenesis disorder 1A (Zellweger),AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,PGM1,full=5,PGM1-CDG,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,PHGDH,full=5,PHGDH deficiency;neurometabolic disorder due to serine deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,q24.3,PIGC,full=5,glycosylphosphatidylinositol biosynthesis defect 16,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p31.1,PIGK,full=5,"neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.2,PIGM,full=5,hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.11,PIGV,full=5,hyperphosphatasia with intellectual disability syndrome 1,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.12,PINK1,full=5,autosomal recessive early-onset Parkinson disease 6,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q22,PKLR,full=5,pyruvate kinase deficiency of red cells;pyruvate kinase hyperactivity,AD;AR,Definitive;Limited,Delly,5'UTR-3'UTR
1,q32.1,PKP1,full=5,epidermolysis bullosa simplex due to plakophilin deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,PLA2G2A,full=5,colorectal cancer,AD,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q31.1,PLA2G4A,full=5,cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q32.1,PLEKHA6,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.31,PLEKHG5,full=5,Charcot-Marie-Tooth disease recessive intermediate c;autosomal recessive lower motor neuron disease with childhood onset,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.22,PLOD1,full=5,"Ehlers-Danlos syndrome, kyphoscoliotic type 1",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.3,PMVK,full=5,POROK1,AD,Moderate,Delly,5'UTR-3'UTR
1,q21.3,POGZ,full=5,"intellectual disability, autosomal dominant 40;intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,POMGNT1,full=5,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.2,PPCS,full=5,"cardiomyopathy, dilated, 2c",AR,Moderate,Delly,5'UTR-3'UTR
1,q23.3,PPOX,full=5,variegate porphyria,AD;AR,Strong,Delly,5'UTR-3'UTR
1,q32.1,PPP1R15B,full=5,"microcephaly, short stature, and impaired glucose metabolism 2",AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,PPT1,full=5,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q31.1,PRG4,full=5,camptodactyly-arthropathy-coxa vara-pericarditis syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,PRPF3,full=5,retinitis pigmentosa 18,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.3,PRUNE1,full=5,"neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies",AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,PTCH2,full=5,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q41-q32.3,PTPN14,full=5,lymphedema-posterior choanal atresia syndrome,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.1-q31.3,PTPRC,full=5,"severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,PTPRF,full=5,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Delly,5'UTR-3'UTR
1,q41,RAB3GAP2,full=5,cataract-intellectual disability-hypogonadism syndrome,AR,Definitive,Delly,5'UTR-3'UTR
1,q21.1,RBM8A,full=5,thrombocytopenia-absent radius syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.3,RD3,full=5,Leber congenital amaurosis 12,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.23,RERE,full=5,"neurodevelopmental disorder with or without anomalies of the brain, eye, or heart",AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,RGS5,full=5,"essential hypertension, genetic",NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q22,RIT1,full=5,Noonan syndrome;Noonan syndrome 8,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,ROR1,full=5,"deafness, autosomal recessive 108;nonsyndromic genetic deafness",AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,q21.3,RORC,full=5,autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,p31.3,RPE65,full=5,Leber congenital amaurosis 9,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.11,RPL11,full=5,Diamond-Blackfan anemia 7,AD,Strong,Delly,5'UTR-3'UTR
1,p22.1,RPL5,full=5,Diamond-Blackfan anemia 6,AD,Strong,Delly,5'UTR-3'UTR
1,p34.3,RSPO1,full=5,palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p21.2,SASS6,full=5,"microcephaly 14, primary, autosomal recessive",AR,Moderate,Delly,5'UTR-3'UTR
1,p36.13,SDHB,full=5,Carney-Stratakis syndrome;gastrointestinal stromal tumor;hereditary pheochromocytoma-paraganglioma;paragangliomas 4;renal cell carcinoma (disease),AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.3,SDHC,full=5,Carney-Stratakis syndrome;gastrointestinal stromal tumor;hereditary pheochromocytoma-paraganglioma;paragangliomas 3;renal cell carcinoma (disease),AD,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.3,SELENBP1,full=5,extraoral halitosis due to methanethiol oxidase deficiency;schizophrenia (disease),AR,Limited;No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.11,SELENON,full=5,SELENON-related myopathy,AR,Definitive,Delly,5'UTR-3'UTR
1,q25.1,SERPINC1,full=5,antithrombin III deficiency,AD;AR;sD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,SF3B4,full=5,Nager acrofacial dysostosis,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.33-p36.32,SKI,full=5,Shprintzen-Goldberg syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.2,SLC16A1,full=5,ketoacidosis due to monocarboxylate transporter-1 deficiency,sD,Moderate,Delly,5'UTR-3'UTR
1,q24.2,SLC19A2,full=5,thiamine-responsive megaloblastic anemia syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,SLC25A24,full=5,"progeroid syndrome, Petty type",AD,Strong,Delly,5'UTR-3'UTR
1,p34.2,SLC2A1,full=5,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q41,SLC30A10,full=5,cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p21.2,SLC35A3,full=5,autism spectrum disorder - epilepsy - arthrogryposis syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,SLC35D1,full=5,schneckenbecken dysplasia,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,SLC6A17,full=5,progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome;schizophrenia (disease),AR,No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p34.1,SLC6A9,full=5,atypical glycine encephalopathy,AR,Strong,Delly,5'UTR-3'UTR
1,p36.11,SLC9A1,full=5,Lichtenstein-Knorr syndrome,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,q32.1,SNRPE,full=5,hypotrichosis 11,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p12,SPAG17,full=5,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Moderate,Delly,5'UTR-3'UTR
1,q23.1,SPTA1,full=5,elliptocytosis 2;hereditary spherocytosis type 3,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=5,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p33,STIL,full=5,"microcephaly 7, primary, autosomal recessive",AR,Strong,Delly,5'UTR-3'UTR
1,q32.1,SYT2,full=5,congenital myasthenic syndrome 7,AD;AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p32.1,TACSTD2,full=5,gelatinous drop-like corneal dystrophy,AR,Strong,Delly,5'UTR-3'UTR
1,p36.22,TARDBP,full=5,amyotrophic lateral sclerosis type 10,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,TBX15,full=5,pelviscapular dysplasia,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.2,TBX19,full=5,congenital isolated adrenocorticotropic hormone deficiency (disease),AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q41,TGFB2,full=5,Loeys-Dietz syndrome 4;familial thoracic aortic aneurysm and aortic dissection,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q22,THBS3,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q24.1,TMCO1,full=5,cerebrofaciothoracic dysplasia,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.33,TMEM240,full=5,spinocerebellar ataxia type 21,AD,Strong,Delly,5'UTR-3'UTR
1,p31.1,TNNI3K,full=5,Primary dilated cardiomyopathy;atrial conduction disease,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.1,TNNT2,full=5,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;arrhythmogenic right ventricular cardiomyopathy;dilated cardiomyopathy 1D;hypertrophic cardiomyopathy 2,AD,Definitive;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p34.1,TOE1,full=5,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q25.2,TOR1AIP1,full=5,autosomal recessive limb-girdle muscular dystrophy type 2Y,AR,Moderate,Delly,5'UTR-3'UTR
1,q41,TP53BP2,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.3,TPM3,full=5,TPM3-related myopathy;congenital fiber-type disproportion myopathy;nemaline myopathy 1,sD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p34.2,TRIT1,full=5,combined oxidative phosphorylation deficiency 35,AR,Strong,Delly,5'UTR-3'UTR
1,q25.3,TSEN15,full=5,"pontocerebellar hypoplasia, type 2F",AR,Strong,Delly,5'UTR-3'UTR
1,p13.2,TSHB,full=5,isolated thyroid-stimulating hormone deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.1,UBE2T,full=5,Fanconi anemia complementation group T,AR,Strong,Delly,5'UTR-3'UTR
1,p36.22,UBIAD1,full=5,Schnyder corneal dystrophy,AD,Strong,Delly,5'UTR-3'UTR
1,q23.3,UFC1,full=5,neurodevelopmental disorder with spasticity and poor growth,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,UROD,full=5,familial porphyria cutanea tarda,AD;AR,Strong,Delly,5'UTR-3'UTR
1,q41,USH2A,full=5,Usher syndrome type 2;Usher syndrome type 2A,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,USP1,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.12,USP48,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q23.2,VANGL2,full=5,"neural tube defects, susceptibility to",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.22-p36.21,VPS13D,full=5,Leigh syndrome;autosomal recessive cerebellar ataxia-saccadic intrusion syndrome,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p13.2,WNT2B,full=5,diarrhea 9,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.12,WNT4,full=5,SERKAL syndrome;mullerian aplasia and hyperandrogenism,AD;AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q25.3,XPR1,full=5,"basal ganglia calcification, idiopathic, 6",AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p35.1,YARS1,full=5,Charcot-Marie-Tooth disease,AD,Definitive,Delly,5'UTR-3'UTR
1,q22,YY1AP1,full=5,grange syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=5,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p22.1,ABCA4,full=5,cone-rod dystrophy 3;severe early-childhood-onset retinal dystrophy,AR,Definitive,Delly,5'UTR-3'UTR
1,p31.1,ACADM,full=5,medium chain acyl-CoA dehydrogenase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,ADAMTSL4,full=5,"ectopia lentis 2, isolated, autosomal recessive;ectopia lentis et pupillae",AR,Strong,Delly,5'UTR-3'UTR
1,q21.3,ADAR,full=5,Aicardi-Goutieres syndrome 6;Leigh syndrome;dyschromatosis symmetrica hereditaria,AD;AR,Definitive;Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q24.2,ADCY10,full=5,"hypercalciuria, absorptive, 2",AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p21.2,AGL,full=5,glycogen storage disease III,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.33,AGRN,full=5,congenital myasthenic syndrome 8,AR,Strong,Delly,5'UTR-3'UTR
1,p36.11-p35.3,AHDC1,full=5,AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p35.1,AK2,full=5,reticular dysgenesis,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.13,ALDH4A1,full=5,hyperprolinemia type 2,AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p21.3,ALG14,full=5,congenital myasthenic syndrome 15,AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,ALG6,full=5,congenital disorder of glycosylation type 1C,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,ALPL,full=5,adult hypophosphatasia;childhood hypophosphatasia;hypophosphatasia;infantile hypophosphatasia,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,ALX3,full=5,frontorhiny,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.2,AMPD1,full=5,myopathy due to myoadenylate deaminase deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p13.3,AMPD2,full=5,pontocerebellar hypoplasia type 9,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,ANGPTL3,full=5,familial hypobetalipoproteinemia 2,AR,Moderate,Delly,5'UTR-3'UTR
1,p13.2,AP4B1,full=5,AP-4 deficiency syndrome;hereditary spastic paraplegia 47,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p22.1,ARHGAP29,full=5,cleft lip with or without cleft palate,AD,Definitive,Delly,5'UTR-3'UTR
1,p36.11,ARID1A,full=5,"Coffin-Siris syndrome;Coffin-Siris syndrome 1;intellectual disability, autosomal dominant 14",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.1,ARL8A,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q22,ASH1L,full=5,"intellectual disability, autosomal dominant 40;intellectual disability, autosomal dominant 52",AD,Strong,Delly,5'UTR-3'UTR
1,q31.3,ASPM,full=5,"microcephaly 5, primary, autosomal recessive",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.33,ATAD3A,full=5,"pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal",AR,Strong,Delly,5'UTR-3'UTR
1,q23.3,ATF6,full=5,achromatopsia;achromatopsia 7,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,ATP13A2,full=5,Kufor-Rakeb syndrome;autosomal recessive spastic paraplegia type 78,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.1,ATP1A1,full=5,"charcot-marie-tooth disease, axonal, type 2DD;hypomagnesemia, seizures, and intellectual disability 2",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q23.2,ATP1A2,full=5,"alternating hemiplegia of childhood 1;familial or sporadic hemiplegic migraine;migraine, familial hemiplegic, 2",AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p36.33,B3GALT6,full=5,"Ehlers-Danlos syndrome, progeroid type, 2;spondyloepimetaphyseal dysplasia with joint laxity, type 1, with or without fractures",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,BSND,full=5,Bartter disease type 4a,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,C1QA,full=5,C1Q deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.12,C1QB,full=5,C1Q deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.12,C1QC,full=5,C1Q deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p32.2,C8B,full=5,type II complement component 8 deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,q25.3,CACNA1E,full=5,"developmental and epileptic encephalopathy, 69",AD,Strong,Delly,5'UTR-3'UTR
1,q32.1,CACNA1S,full=5,"congenital myopathy;hypokalemic periodic paralysis, type 1;malignant hyperthermia, susceptibility to, 5",AD;AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.31-p36.23,CAMTA1,full=5,nonprogressive cerebellar atxia with mental retardation,AD,Strong,Delly,5'UTR-3'UTR
1,p13.1,CASQ2,full=5,Hypertrophic cardiomyopathy;catecholaminergic polymorphic ventricular tachycardia;catecholaminergic polymorphic ventricular tachycardia 2,AD;AR,Definitive;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p35.2,CCDC28B,full=5,Bardet-Biedl syndrome 1,AR,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q24.2,CD247,full=5,immunodeficiency 25,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.2,CD46,full=5,atypical hemolytic-uremic syndrome with MCP/CD46 anomaly,AD;sD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p21.2,CDC14A,full=5,autosomal recessive nonsyndromic deafness 105;autosomal recessive nonsyndromic deafness 32;hearing impairment and infertile male syndrome;nonsyndromic genetic deafness,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.12,CDC42,full=5,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,q31.2,CDC73,full=5,hyperparathyroidism-jaw tumor syndrome,AD,Definitive,Delly,5'UTR-3'UTR
1,q41,CENPF,full=5,Stromme syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p36.32,CEP104,full=5,Joubert syndrome 17;Joubert syndrome 25,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q31.3,CFHR5,full=5,C3 glomerulonephritis,AD,Strong,Delly,5'UTR-3'UTR
1,q32.1,CHI3L1,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.3,CHRNB2,full=5,autosomal dominant nocturnal frontal lobe epilepsy 3,AD,Strong,Delly,5'UTR-3'UTR
1,p22.3,CLCA2,full=5,heart conduction disease,AD,Moderate,Delly,5'UTR-3'UTR
1,p36.13,CLCNKA,full=5,Bartter disease type 4B,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.13,CLCNKB,full=5,Bartter disease type 4B,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,CLDN19,full=5,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,COA7,full=5,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p21.1,COL11A1,full=5,Marshall syndrome;Stickler syndrome type 2;fibrochondrogenesis 1,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p22.3,COL24A1,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.2,COL9A2,full=5,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q25.3,COLGALT2,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q23.2,COPA,full=5,autoimmune interstitial lung disease-arthritis syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,p32.3,CPT2,full=5,"Carnitine palmitoyltransferase II deficiency;carnitine palmitoyl transferase II deficiency, myopathic form;carnitine palmitoyl transferase II deficiency, neonatal form;carnitine palmitoyl transferase II deficiency, severe infantile form",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.2,CR2,full=5,"immunodeficiency, common variable, 7",AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,q31.3,CRB1,full=5,Leber congenital amaurosis 8,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.3,CSF3R,full=5,autosomal recessive severe congenital neutropenia due to CSF3R deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p31.1,CTH,full=5,cystathioninuria (disease),AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p34.2,CTPS1,full=5,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p36.21,CTRC,full=5,hereditary chronic pancreatitis,AD,Definitive,Delly,5'UTR-3'UTR
1,q21.3,CTSK,full=5,pycnodysostosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q25.1,DARS2,full=5,leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p21.2,DBT,full=5,maple syrup urine disease;maple syrup urine disease type 2,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.3,DCST1,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.12,DDOST,full=5,DDOST-CDG,AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,q23.3,DDR2,full=5,spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome;warburg-cinotti syndrome,AD;AR,Definitive;Limited;Moderate,Delly,5'UTR-3'UTR
1,q32.1,DDX59,full=5,orofaciodigital syndrome V,AR,Strong,Delly,5'UTR-3'UTR
1,p32.3,DHCR24,full=5,desmosterolosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,DNAJC6,full=5,juvenile onset Parkinson disease 19A,AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p31.3,DOCK7,full=5,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q22,DPM3,full=5,DPM3-CDG,AR,Strong,Delly,5'UTR-3'UTR
1,p13.3,DRAM2,full=5,cone-rod dystrophy 21,AR,Strong,Delly,5'UTR-3'UTR
1,q32.1,DSTYK,full=5,"congenital anomalies of kidney and urinary tract 1, susceptibility to",AD;AR,Definitive;Limited,Delly,5'UTR-3'UTR
1,p36.33,DVL1,full=5,autosomal dominant Robinow syndrome 2,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,ECE1,full=5,"essential hypertension, genetic",NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.2,ECM1,full=5,lipoid proteinosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,EIF2B3,full=5,leukoencephalopathy with vanishing white matter,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ELOVL1,full=5,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.13,EMC1,full=5,"cerebellar atrophy, visual impairment, and psychomotor retardation;",AR,Moderate,Delly,5'UTR-3'UTR
1,p35.3,EPB41,full=5,elliptocytosis 1,AR,Strong,Delly,5'UTR-3'UTR
1,p36.31,ESPN,full=5,autosomal recessive nonsyndromic deafness 36;nonsyndromic genetic deafness,AD;AR,Definitive;Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q31.3,F13B,full=5,"factor XIII, b subunit, deficiency of",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.2,F5,full=5,congenital factor V deficiency;thrombophilia due to activated protein C resistance,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.3,FAM71A,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q24.3,FASLG,full=5,autoimmune lymphoproliferative syndrome type 1,AR,Moderate,Delly,5'UTR-3'UTR
1,q23.3,FCGR2B,full=5,systemic lupus erythematosus (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q22,FDPS,full=5,"porokeratosis 9, multiple types",AD,Strong,Delly,5'UTR-3'UTR
1,q21.3,FLAD1,full=5,myopathy with abnormal lipid metabolism,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.3,FLG,full=5,autosomal dominant ichthyosis vulgaris,AD;AR;sD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q21.3,FLG2,full=5,peeling skin syndrome 6,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.3,FLVCR1,full=5,posterior column ataxia-retinitis pigmentosa syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.3,FMO3,full=5,trimethylaminuria (disease),AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p33,FOXE3,full=5,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.11,FUCA1,full=5,fucosidosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11,GALE,full=5,galactose epimerase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.3,GATAD2B,full=5,severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,q22,GBA,full=5,Gaucher disease;Gaucher disease perinatal lethal;Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;late-onset Parkinson disease,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,GJA5,full=5,"atrial fibrillation, familial, 11;heart conduction disease",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.3,GJB3,full=5,autosomal dominant nonsyndromic deafness 2B;erythrokeratodermia variabilis;erythrokeratodermia variabilis et progressiva 1;nonsyndromic genetic deafness,AD;AR,Disputed Evidence;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.3,GJB4,full=5,erythrokeratodermia variabilis et progressiva 2,AD;AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p22.1,GLMN,full=5,glomuvenous malformation,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q25.3,GLUL,full=5,congenital brain dysgenesis due to glutamine synthetase deficiency,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.3,GNAI3,full=5,auriculocondylar syndrome 1,AD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p13.3,GNAT2,full=5,achromatopsia 4,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.33,GNB1,full=5,"intellectual disability, autosomal dominant 42",AD,Moderate,Delly,5'UTR-3'UTR
1,q24.2,GORAB,full=5,geroderma osteodysplastica,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.3,GPSM2,full=5,Chudley-McCullough syndrome,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.11,GRHL3,full=5,van der Woude syndrome 1;van der Woude syndrome 2,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.22,H6PD,full=5,cortisone reductase deficiency 1,AR,Moderate,Delly,5'UTR-3'UTR
1,q21.3,HAX1,full=5,Kostmann syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p22.2,HFM1,full=5,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Disputed Evidence,Delly,5'UTR-3'UTR
1,q32.2,HHAT,full=5,chondrodysplasia-pseudohermaphroditism syndrome,AR,Moderate,Delly,5'UTR-3'UTR
1,q21.1,HJV,full=5,hemochromatosis type 2A,AR,Strong,Delly,5'UTR-3'UTR
1,p36.11,HMGCL,full=5,3-hydroxy-3-methylglutaric aciduria,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,HMGCS2,full=5,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,HNRNPR,full=5,"intellectual disability, autosomal dominant 40",AD,Definitive,Delly,5'UTR-3'UTR
1,q21.3,HORMAD1,full=5,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Moderate,Delly,5'UTR-3'UTR
1,p35.1,HPCA,full=5,torsion dystonia 2,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,HPDL,full=5,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Delly,5'UTR-3'UTR
1,p12,HSD3B2,full=5,congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p36.12,HSPG2,full=5,Silverman-Handmaker type dyssegmental dysplasia,AR,Definitive,Delly,5'UTR-3'UTR
1,q23.1,INSRR,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q32.2,IRF6,full=5,autosomal dominant popliteal pterygium syndrome;van der Woude syndrome 1,AD,Definitive,Delly,5'UTR-3'UTR
1,p36.33,ISG15,full=5,mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p13.3,KCNA2,full=5,infantile epilepsy syndrome;undetermined early-onset epileptic encephalopathy,AD,Strong,Delly,5'UTR-3'UTR
1,p13.2,KCND3,full=5,Brugada syndrome 1;Brugada syndrome 9;spinocerebellar ataxia type 19/22,AD,Disputed Evidence;Limited;Strong,Delly,5'UTR-3'UTR
1,q32.2,KCNH1,full=5,Temple-Baraitser syndrome;Zimmermann-Laband syndrome 1,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.2,KCNJ10,full=5,EAST syndrome;enlarged vestibular aqueduct syndrome,AD;AR,Definitive;Disputed Evidence;Strong,Delly,5'UTR-3'UTR
1,p34.2,KCNQ4,full=5,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q31.3,KCNT2,full=5,"developmental and epileptic encephalopathy, 57",AD,Moderate,Delly,5'UTR-3'UTR
1,p36.12,KDM1A,full=5,palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q32.1,KDM5B,full=5,Tourette syndrome;autism susceptibility 1,AD,No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,q32.1,KIF14,full=5,lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.12,KIF17,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.22,KIF1B,full=5,"Charcot-Marie-Tooth disease type 2A1;neuroblastoma, susceptibility to;phaeochromocytoma",AD,Limited;Moderate;No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q32.2,LAMB3,full=5,"amelogenesis imperfecta type 1A;junctional epidermolysis bullosa;junctional epidermolysis bullosa Herlitz type;junctional epidermolysis bullosa, non-Herlitz type",AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q25.3,LAMC2,full=5,"junctional epidermolysis bullosa;junctional epidermolysis bullosa Herlitz type;junctional epidermolysis bullosa, non-Herlitz type",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11,LDLRAP1,full=5,"hypercholesterolemia, familial, 4",AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,LEPR,full=5,obesity due to leptin receptor gene deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,q25.2,LHX4,full=5,short stature-pituitary and cerebellar defects-small sella turcica syndrome,AD,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q22,LMNA,full=5,"Charcot-Marie-Tooth disease type 2B1;Emery-Dreifuss muscular dystrophy 2, autosomal dominant;Hutchinson-Gilford progeria syndrome;Primary dilated cardiomyopathy;arrhythmogenic right ventricular cardiomyopathy;atrioventricular block (disease);dilated cardiomyopathy 1A;familial partial lipodystrophy, Dunnigan type;heart-hand syndrome, Slovenian type",AD;AR;sD,Definitive;Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,LMX1A,full=5,autosomal dominant nonsyndromic deafness 7,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,q21.3,LORICRIN,full=5,keratoderma hereditarium mutilans with ichthyosis,AD,Strong,Delly,5'UTR-3'UTR
1,p13.2,LRIG2,full=5,urofacial syndrome 2;urofacial syndrome type 1,AR,Strong,Delly,5'UTR-3'UTR
1,p32.3,LRP8,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.3,MACF1,full=5,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.22,MASP2,full=5,immunodeficiency due to MASP-2 deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p35.3,MECR,full=5,"Leigh syndrome;dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,MFSD2A,full=5,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,MMACHC,full=5,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,MPL,full=5,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,MPZ,full=5,Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease type 1B,AD,Definitive,Delly,5'UTR-3'UTR
1,q22,MSTO1,full=5,mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.22,MTHFR,full=5,homocystinuria due to methylene tetrahydrofolate reductase deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.22,MTOR,full=5,macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q22,MUC1,full=5,medullary cystic kidney disease 1,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.1,MUTYH,full=5,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,q24.3,MYOC,full=5,"glaucoma 1, open angle, A;glaucoma 3A",AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q25.3,NCF2,full=5,"granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.2,NCSTN,full=5,"acne inversa, familial, 1",AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,NDUFS2,full=5,"Leigh syndrome;mitochondrial complex 1 deficiency, nuclear type 6",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.3,NECTIN4,full=5,ectodermal dysplasia-syndactyly syndrome 1,AR,Moderate,Delly,5'UTR-3'UTR
1,p31.1,NEXN,full=5,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;hypertrophic cardiomyopathy 20,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q32.1,NFASC,full=5,neurodevelopmental disorder with central and peripheral motor dysfunction,AD;AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p31.3,NFIA,full=5,chromosome 1p32-p31 deletion syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,p36.22,NMNAT1,full=5,Leber congenital amaurosis 9,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,NOTCH2,full=5,Alagille syndrome;acroosteolysis dominant type,AD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p36.31,NPHP4,full=5,nephronophthisis 4,AR,Definitive,Delly,5'UTR-3'UTR
1,q25.2,NPHS2,full=5,"nephrotic syndrome, type 2",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.22,NPPA,full=5,"Primary dilated cardiomyopathy;atrial fibrillation, familial, 6",AD;AR,Moderate;No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.11,NR0B2,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p13.2,NRAS,full=5,Costello syndrome;Noonan syndrome;Noonan syndrome 6;Noonan syndrome with multiple lentigines;cardiofaciocutaneous syndrome,AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q23.1,NTRK1,full=5,hereditary sensory and autonomic neuropathy type 4,AR,Definitive,Delly,5'UTR-3'UTR
1,p32.3,ORC1,full=5,Meier-Gorlin syndrome 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,P3H1,full=5,osteogenesis imperfecta type 8,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,PADI3,full=5,uncombable hair syndrome 1,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.23,PARK7,full=5,autosomal recessive early-onset Parkinson disease 7,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p32.3,PARS2,full=5,"developmental and epileptic encephalopathy, 75",AR,Moderate,Delly,5'UTR-3'UTR
1,p36.13,PAX7,full=5,"congenital myopathy with myasthenic-like onset;myopathy, congenital, progressive, with scoliosis",AR,Moderate,Delly,5'UTR-3'UTR
1,q23.3,PBX1,full=5,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",AD,Strong,Delly,5'UTR-3'UTR
1,p32.3,PCSK9,full=5,"hypercholesterolemia, autosomal dominant, 3",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.32,PEX10,full=5,peroxisome biogenesis disorder;peroxisome biogenesis disorder 6A (Zellweger);peroxisome biogenesis disorder 6B,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.1,PEX11B,full=5,peroxisome biogenesis disorder;peroxisome biogenesis disorder 14B,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.22,PEX14,full=5,peroxisome biogenesis disorder;peroxisome biogenesis disorder 13A (Zellweger),AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.2,PEX19,full=5,peroxisome biogenesis disorder;peroxisome biogenesis disorder 12A (Zellweger);peroxisome biogenesis disorder 1A (Zellweger),AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,PGM1,full=5,PGM1-CDG,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,PHGDH,full=5,PHGDH deficiency;neurometabolic disorder due to serine deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,q24.3,PIGC,full=5,glycosylphosphatidylinositol biosynthesis defect 16,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p31.1,PIGK,full=5,"neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.2,PIGM,full=5,hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.11,PIGV,full=5,hyperphosphatasia with intellectual disability syndrome 1,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.12,PINK1,full=5,autosomal recessive early-onset Parkinson disease 6,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q22,PKLR,full=5,pyruvate kinase deficiency of red cells;pyruvate kinase hyperactivity,AD;AR,Definitive;Limited,Delly,5'UTR-3'UTR
1,q32.1,PKP1,full=5,epidermolysis bullosa simplex due to plakophilin deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,PLA2G2A,full=5,colorectal cancer,AD,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q31.1,PLA2G4A,full=5,cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q32.1,PLEKHA6,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.31,PLEKHG5,full=5,Charcot-Marie-Tooth disease recessive intermediate c;autosomal recessive lower motor neuron disease with childhood onset,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.22,PLOD1,full=5,"Ehlers-Danlos syndrome, kyphoscoliotic type 1",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.3,PMVK,full=5,POROK1,AD,Moderate,Delly,5'UTR-3'UTR
1,q21.3,POGZ,full=5,"intellectual disability, autosomal dominant 40;intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,POMGNT1,full=5,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.2,PPCS,full=5,"cardiomyopathy, dilated, 2c",AR,Moderate,Delly,5'UTR-3'UTR
1,q23.3,PPOX,full=5,variegate porphyria,AD;AR,Strong,Delly,5'UTR-3'UTR
1,q32.1,PPP1R15B,full=5,"microcephaly, short stature, and impaired glucose metabolism 2",AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,PPT1,full=5,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q31.1,PRG4,full=5,camptodactyly-arthropathy-coxa vara-pericarditis syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,PRPF3,full=5,retinitis pigmentosa 18,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.3,PRUNE1,full=5,"neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies",AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,PTCH2,full=5,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q41-q32.3,PTPN14,full=5,lymphedema-posterior choanal atresia syndrome,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.1-q31.3,PTPRC,full=5,"severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,PTPRF,full=5,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Delly,5'UTR-3'UTR
1,q41,RAB3GAP2,full=5,cataract-intellectual disability-hypogonadism syndrome,AR,Definitive,Delly,5'UTR-3'UTR
1,q21.1,RBM8A,full=5,thrombocytopenia-absent radius syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.3,RD3,full=5,Leber congenital amaurosis 12,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.23,RERE,full=5,"neurodevelopmental disorder with or without anomalies of the brain, eye, or heart",AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,RGS5,full=5,"essential hypertension, genetic",NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q22,RIT1,full=5,Noonan syndrome;Noonan syndrome 8,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,ROR1,full=5,"deafness, autosomal recessive 108;nonsyndromic genetic deafness",AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,q21.3,RORC,full=5,autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,p31.3,RPE65,full=5,Leber congenital amaurosis 9,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.11,RPL11,full=5,Diamond-Blackfan anemia 7,AD,Strong,Delly,5'UTR-3'UTR
1,p22.1,RPL5,full=5,Diamond-Blackfan anemia 6,AD,Strong,Delly,5'UTR-3'UTR
1,p34.3,RSPO1,full=5,palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p21.2,SASS6,full=5,"microcephaly 14, primary, autosomal recessive",AR,Moderate,Delly,5'UTR-3'UTR
1,p36.13,SDHB,full=5,Carney-Stratakis syndrome;gastrointestinal stromal tumor;hereditary pheochromocytoma-paraganglioma;paragangliomas 4;renal cell carcinoma (disease),AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.3,SDHC,full=5,Carney-Stratakis syndrome;gastrointestinal stromal tumor;hereditary pheochromocytoma-paraganglioma;paragangliomas 3;renal cell carcinoma (disease),AD,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.3,SELENBP1,full=5,extraoral halitosis due to methanethiol oxidase deficiency;schizophrenia (disease),AR,Limited;No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.11,SELENON,full=5,SELENON-related myopathy,AR,Definitive,Delly,5'UTR-3'UTR
1,q25.1,SERPINC1,full=5,antithrombin III deficiency,AD;AR;sD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,SF3B4,full=5,Nager acrofacial dysostosis,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.33-p36.32,SKI,full=5,Shprintzen-Goldberg syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.2,SLC16A1,full=5,ketoacidosis due to monocarboxylate transporter-1 deficiency,sD,Moderate,Delly,5'UTR-3'UTR
1,q24.2,SLC19A2,full=5,thiamine-responsive megaloblastic anemia syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,SLC25A24,full=5,"progeroid syndrome, Petty type",AD,Strong,Delly,5'UTR-3'UTR
1,p34.2,SLC2A1,full=5,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q41,SLC30A10,full=5,cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p21.2,SLC35A3,full=5,autism spectrum disorder - epilepsy - arthrogryposis syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,SLC35D1,full=5,schneckenbecken dysplasia,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,SLC6A17,full=5,progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome;schizophrenia (disease),AR,No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p34.1,SLC6A9,full=5,atypical glycine encephalopathy,AR,Strong,Delly,5'UTR-3'UTR
1,p36.11,SLC9A1,full=5,Lichtenstein-Knorr syndrome,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,q32.1,SNRPE,full=5,hypotrichosis 11,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p12,SPAG17,full=5,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Moderate,Delly,5'UTR-3'UTR
1,q23.1,SPTA1,full=5,elliptocytosis 2;hereditary spherocytosis type 3,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=5,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p33,STIL,full=5,"microcephaly 7, primary, autosomal recessive",AR,Strong,Delly,5'UTR-3'UTR
1,q32.1,SYT2,full=5,congenital myasthenic syndrome 7,AD;AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p32.1,TACSTD2,full=5,gelatinous drop-like corneal dystrophy,AR,Strong,Delly,5'UTR-3'UTR
1,p36.22,TARDBP,full=5,amyotrophic lateral sclerosis type 10,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,TBX15,full=5,pelviscapular dysplasia,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.2,TBX19,full=5,congenital isolated adrenocorticotropic hormone deficiency (disease),AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q41,TGFB2,full=5,Loeys-Dietz syndrome 4;familial thoracic aortic aneurysm and aortic dissection,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q22,THBS3,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q24.1,TMCO1,full=5,cerebrofaciothoracic dysplasia,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.33,TMEM240,full=5,spinocerebellar ataxia type 21,AD,Strong,Delly,5'UTR-3'UTR
1,p31.1,TNNI3K,full=5,Primary dilated cardiomyopathy;atrial conduction disease,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.1,TNNT2,full=5,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;arrhythmogenic right ventricular cardiomyopathy;dilated cardiomyopathy 1D;hypertrophic cardiomyopathy 2,AD,Definitive;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p34.1,TOE1,full=5,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q25.2,TOR1AIP1,full=5,autosomal recessive limb-girdle muscular dystrophy type 2Y,AR,Moderate,Delly,5'UTR-3'UTR
1,q41,TP53BP2,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.3,TPM3,full=5,TPM3-related myopathy;congenital fiber-type disproportion myopathy;nemaline myopathy 1,sD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p34.2,TRIT1,full=5,combined oxidative phosphorylation deficiency 35,AR,Strong,Delly,5'UTR-3'UTR
1,q25.3,TSEN15,full=5,"pontocerebellar hypoplasia, type 2F",AR,Strong,Delly,5'UTR-3'UTR
1,p13.2,TSHB,full=5,isolated thyroid-stimulating hormone deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.1,UBE2T,full=5,Fanconi anemia complementation group T,AR,Strong,Delly,5'UTR-3'UTR
1,p36.22,UBIAD1,full=5,Schnyder corneal dystrophy,AD,Strong,Delly,5'UTR-3'UTR
1,q23.3,UFC1,full=5,neurodevelopmental disorder with spasticity and poor growth,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,UROD,full=5,familial porphyria cutanea tarda,AD;AR,Strong,Delly,5'UTR-3'UTR
1,q41,USH2A,full=5,Usher syndrome type 2;Usher syndrome type 2A,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,USP1,full=5,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.12,USP48,full=5,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q23.2,VANGL2,full=5,"neural tube defects, susceptibility to",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.22-p36.21,VPS13D,full=5,Leigh syndrome;autosomal recessive cerebellar ataxia-saccadic intrusion syndrome,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p13.2,WNT2B,full=5,diarrhea 9,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.12,WNT4,full=5,SERKAL syndrome;mullerian aplasia and hyperandrogenism,AD;AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q25.3,XPR1,full=5,"basal ganglia calcification, idiopathic, 6",AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p35.1,YARS1,full=5,Charcot-Marie-Tooth disease,AD,Definitive,Delly,5'UTR-3'UTR
1,q22,YY1AP1,full=5,grange syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=5,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.12,HSPG2,full=5,Silverman-Handmaker type dyssegmental dysplasia,AR,Definitive,Delly,5'UTR-3'UTR
20,p12.3,PLCB1,full=3,"developmental and epileptic encephalopathy, 12",AR,Definitive;Moderate;Strong,Delly,CDS
20,q13.12,HNF4A,full=3,"Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young;diabetes mellitus, noninsulin-dependent;maturity-onset diabetes of the young type 1;monogenic diabetes",AD,Definitive;Strong,Delly,CDS
20,q13.33,KCNQ2,full=3,"developmental and epileptic encephalopathy, 7;seizures, benign familial neonatal, 1;undetermined early-onset epileptic encephalopathy",AD,Definitive,Delly,CDS
20,q13.33,EEF1A2,full=3,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 33",AD,Definitive;Moderate,Delly,CDS
1,p36.23,CAMTA1,full=1,nonprogressive cerebellar atxia with mental retardation,AD,Strong,Delly,CDS
1,p22.1,ABCA4,full=NA,cone-rod dystrophy 3;severe early-childhood-onset retinal dystrophy,AR,Definitive,Delly,5'UTR-3'UTR
1,p31.1,ACADM,full=NA,medium chain acyl-CoA dehydrogenase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p21.2,AGL,full=NA,glycogen storage disease III,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11-p35.3,AHDC1,full=NA,AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p35.1,AK2,full=NA,reticular dysgenesis,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.13,ALDH4A1,full=NA,hyperprolinemia type 2,AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p21.3,ALG14,full=NA,congenital myasthenic syndrome 15,AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,ALG6,full=NA,congenital disorder of glycosylation type 1C,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,ALPL,full=NA,adult hypophosphatasia;childhood hypophosphatasia;hypophosphatasia;infantile hypophosphatasia,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,ALX3,full=NA,frontorhiny,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.2,AMPD1,full=NA,myopathy due to myoadenylate deaminase deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p13.3,AMPD2,full=NA,pontocerebellar hypoplasia type 9,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,ANGPTL3,full=NA,familial hypobetalipoproteinemia 2,AR,Moderate,Delly,5'UTR-3'UTR
1,p13.2,AP4B1,full=NA,AP-4 deficiency syndrome;hereditary spastic paraplegia 47,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p22.1,ARHGAP29,full=NA,cleft lip with or without cleft palate,AD,Definitive,Delly,5'UTR-3'UTR
1,p36.11,ARID1A,full=NA,"Coffin-Siris syndrome;Coffin-Siris syndrome 1;intellectual disability, autosomal dominant 14",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.13,ATP13A2,full=NA,Kufor-Rakeb syndrome;autosomal recessive spastic paraplegia type 78,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.1,ATP1A1,full=NA,"charcot-marie-tooth disease, axonal, type 2DD;hypomagnesemia, seizures, and intellectual disability 2",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p32.3,BSND,full=NA,Bartter disease type 4a,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,C1QA,full=NA,C1Q deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.12,C1QB,full=NA,C1Q deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.12,C1QC,full=NA,C1Q deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p32.2,C8B,full=NA,type II complement component 8 deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,p13.1,CASQ2,full=NA,Hypertrophic cardiomyopathy;catecholaminergic polymorphic ventricular tachycardia;catecholaminergic polymorphic ventricular tachycardia 2,AD;AR,Definitive;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p35.2,CCDC28B,full=NA,Bardet-Biedl syndrome 1,AR,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p21.2,CDC14A,full=NA,autosomal recessive nonsyndromic deafness 105;autosomal recessive nonsyndromic deafness 32;hearing impairment and infertile male syndrome;nonsyndromic genetic deafness,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.12,CDC42,full=NA,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,p22.3,CLCA2,full=NA,heart conduction disease,AD,Moderate,Delly,5'UTR-3'UTR
1,p36.13,CLCNKA,full=NA,Bartter disease type 4B,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.13,CLCNKB,full=NA,Bartter disease type 4B,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,CLDN19,full=NA,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,COA7,full=NA,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p21.1,COL11A1,full=NA,Marshall syndrome;Stickler syndrome type 2;fibrochondrogenesis 1,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p22.3,COL24A1,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.2,COL9A2,full=NA,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p32.3,CPT2,full=NA,"Carnitine palmitoyltransferase II deficiency;carnitine palmitoyl transferase II deficiency, myopathic form;carnitine palmitoyl transferase II deficiency, neonatal form;carnitine palmitoyl transferase II deficiency, severe infantile form",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.3,CSF3R,full=NA,autosomal recessive severe congenital neutropenia due to CSF3R deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p31.1,CTH,full=NA,cystathioninuria (disease),AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p34.2,CTPS1,full=NA,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p36.21,CTRC,full=NA,hereditary chronic pancreatitis,AD,Definitive,Delly,5'UTR-3'UTR
1,p21.2,DBT,full=NA,maple syrup urine disease;maple syrup urine disease type 2,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,DDOST,full=NA,DDOST-CDG,AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p32.3,DHCR24,full=NA,desmosterolosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,DNAJC6,full=NA,juvenile onset Parkinson disease 19A,AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p31.3,DOCK7,full=NA,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.3,DRAM2,full=NA,cone-rod dystrophy 21,AR,Strong,Delly,5'UTR-3'UTR
1,p36.12,ECE1,full=NA,"essential hypertension, genetic",NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.1,EIF2B3,full=NA,leukoencephalopathy with vanishing white matter,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ELOVL1,full=NA,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.13,EMC1,full=NA,"cerebellar atrophy, visual impairment, and psychomotor retardation;",AR,Moderate,Delly,5'UTR-3'UTR
1,p35.3,EPB41,full=NA,elliptocytosis 1,AR,Strong,Delly,5'UTR-3'UTR
1,p33,FOXE3,full=NA,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.11,FUCA1,full=NA,fucosidosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11,GALE,full=NA,galactose epimerase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.3,GJB3,full=NA,autosomal dominant nonsyndromic deafness 2B;erythrokeratodermia variabilis;erythrokeratodermia variabilis et progressiva 1;nonsyndromic genetic deafness,AD;AR,Disputed Evidence;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.3,GJB4,full=NA,erythrokeratodermia variabilis et progressiva 2,AD;AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p22.1,GLMN,full=NA,glomuvenous malformation,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,GNAI3,full=NA,auriculocondylar syndrome 1,AD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p13.3,GNAT2,full=NA,achromatopsia 4,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.3,GPSM2,full=NA,Chudley-McCullough syndrome,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.11,GRHL3,full=NA,van der Woude syndrome 1;van der Woude syndrome 2,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p22.2,HFM1,full=NA,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Disputed Evidence,Delly,5'UTR-3'UTR
1,p36.11,HMGCL,full=NA,3-hydroxy-3-methylglutaric aciduria,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,HNRNPR,full=NA,"intellectual disability, autosomal dominant 40",AD,Definitive,Delly,5'UTR-3'UTR
1,p35.1,HPCA,full=NA,torsion dystonia 2,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,HPDL,full=NA,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.12,HSPG2,full=NA,Silverman-Handmaker type dyssegmental dysplasia,AR,Definitive,Delly,5'UTR-3'UTR
1,p13.3,KCNA2,full=NA,infantile epilepsy syndrome;undetermined early-onset epileptic encephalopathy,AD,Strong,Delly,5'UTR-3'UTR
1,p13.2,KCND3,full=NA,Brugada syndrome 1;Brugada syndrome 9;spinocerebellar ataxia type 19/22,AD,Disputed Evidence;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.2,KCNQ4,full=NA,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,KDM1A,full=NA,palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.12,KIF17,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.11,LDLRAP1,full=NA,"hypercholesterolemia, familial, 4",AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,LEPR,full=NA,obesity due to leptin receptor gene deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p13.2,LRIG2,full=NA,urofacial syndrome 2;urofacial syndrome type 1,AR,Strong,Delly,5'UTR-3'UTR
1,p32.3,LRP8,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.3,MACF1,full=NA,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.22,MASP2,full=NA,immunodeficiency due to MASP-2 deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p35.3,MECR,full=NA,"Leigh syndrome;dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,MFSD2A,full=NA,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,MMACHC,full=NA,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,MPL,full=NA,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.22,MTHFR,full=NA,homocystinuria due to methylene tetrahydrofolate reductase deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.22,MTOR,full=NA,macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,MUTYH,full=NA,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p31.1,NEXN,full=NA,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;hypertrophic cardiomyopathy 20,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p31.3,NFIA,full=NA,chromosome 1p32-p31 deletion syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,p36.22,NPPA,full=NA,"Primary dilated cardiomyopathy;atrial fibrillation, familial, 6",AD;AR,Moderate;No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.11,NR0B2,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p13.2,NRAS,full=NA,Costello syndrome;Noonan syndrome;Noonan syndrome 6;Noonan syndrome with multiple lentigines;cardiofaciocutaneous syndrome,AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p32.3,ORC1,full=NA,Meier-Gorlin syndrome 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,P3H1,full=NA,osteogenesis imperfecta type 8,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,PADI3,full=NA,uncombable hair syndrome 1,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p32.3,PARS2,full=NA,"developmental and epileptic encephalopathy, 75",AR,Moderate,Delly,5'UTR-3'UTR
1,p36.13,PAX7,full=NA,"congenital myopathy with myasthenic-like onset;myopathy, congenital, progressive, with scoliosis",AR,Moderate,Delly,5'UTR-3'UTR
1,p32.3,PCSK9,full=NA,"hypercholesterolemia, autosomal dominant, 3",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,PGM1,full=NA,PGM1-CDG,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.1,PIGK,full=NA,"neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.11,PIGV,full=NA,hyperphosphatasia with intellectual disability syndrome 1,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.12,PINK1,full=NA,autosomal recessive early-onset Parkinson disease 6,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.13,PLA2G2A,full=NA,colorectal cancer,AD,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.22,PLOD1,full=NA,"Ehlers-Danlos syndrome, kyphoscoliotic type 1",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,POMGNT1,full=NA,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.2,PPCS,full=NA,"cardiomyopathy, dilated, 2c",AR,Moderate,Delly,5'UTR-3'UTR
1,p34.2,PPT1,full=NA,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,PTCH2,full=NA,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,ROR1,full=NA,"deafness, autosomal recessive 108;nonsyndromic genetic deafness",AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p31.3,RPE65,full=NA,Leber congenital amaurosis 9,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.11,RPL11,full=NA,Diamond-Blackfan anemia 7,AD,Strong,Delly,5'UTR-3'UTR
1,p22.1,RPL5,full=NA,Diamond-Blackfan anemia 6,AD,Strong,Delly,5'UTR-3'UTR
1,p34.3,RSPO1,full=NA,palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p21.2,SASS6,full=NA,"microcephaly 14, primary, autosomal recessive",AR,Moderate,Delly,5'UTR-3'UTR
1,p36.13,SDHB,full=NA,Carney-Stratakis syndrome;gastrointestinal stromal tumor;hereditary pheochromocytoma-paraganglioma;paragangliomas 4;renal cell carcinoma (disease),AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11,SELENON,full=NA,SELENON-related myopathy,AR,Definitive,Delly,5'UTR-3'UTR
1,p13.2,SLC16A1,full=NA,ketoacidosis due to monocarboxylate transporter-1 deficiency,sD,Moderate,Delly,5'UTR-3'UTR
1,p13.3,SLC25A24,full=NA,"progeroid syndrome, Petty type",AD,Strong,Delly,5'UTR-3'UTR
1,p34.2,SLC2A1,full=NA,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p21.2,SLC35A3,full=NA,autism spectrum disorder - epilepsy - arthrogryposis syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,SLC35D1,full=NA,schneckenbecken dysplasia,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,SLC6A17,full=NA,progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome;schizophrenia (disease),AR,No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p34.1,SLC6A9,full=NA,atypical glycine encephalopathy,AR,Strong,Delly,5'UTR-3'UTR
1,p36.11,SLC9A1,full=NA,Lichtenstein-Knorr syndrome,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p12,SPAG17,full=NA,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Moderate,Delly,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p33,STIL,full=NA,"microcephaly 7, primary, autosomal recessive",AR,Strong,Delly,5'UTR-3'UTR
1,p32.1,TACSTD2,full=NA,gelatinous drop-like corneal dystrophy,AR,Strong,Delly,5'UTR-3'UTR
1,p36.22,TARDBP,full=NA,amyotrophic lateral sclerosis type 10,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.1,TNNI3K,full=NA,Primary dilated cardiomyopathy;atrial conduction disease,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p34.1,TOE1,full=NA,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,TRIT1,full=NA,combined oxidative phosphorylation deficiency 35,AR,Strong,Delly,5'UTR-3'UTR
1,p13.2,TSHB,full=NA,isolated thyroid-stimulating hormone deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.22,UBIAD1,full=NA,Schnyder corneal dystrophy,AD,Strong,Delly,5'UTR-3'UTR
1,p34.1,UROD,full=NA,familial porphyria cutanea tarda,AD;AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,USP1,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.12,USP48,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.22-p36.21,VPS13D,full=NA,Leigh syndrome;autosomal recessive cerebellar ataxia-saccadic intrusion syndrome,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p13.2,WNT2B,full=NA,diarrhea 9,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.12,WNT4,full=NA,SERKAL syndrome;mullerian aplasia and hyperandrogenism,AD;AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p35.1,YARS1,full=NA,Charcot-Marie-Tooth disease,AD,Definitive,Delly,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=NA,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p22.1,ABCA4,full=NA,cone-rod dystrophy 3;severe early-childhood-onset retinal dystrophy,AR,Definitive,Delly,5'UTR-3'UTR
1,p31.1,ACADM,full=NA,medium chain acyl-CoA dehydrogenase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q42.13,ACTA1,full=NA,Hypertrophic cardiomyopathy;actinopathy;nemaline myopathy 3,AD;AR;sD,Definitive;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,q21.2,ADAMTSL4,full=NA,"ectopia lentis 2, isolated, autosomal recessive;ectopia lentis et pupillae",AR,Strong,Delly,5'UTR-3'UTR
1,q21.3,ADAR,full=NA,Aicardi-Goutieres syndrome 6;Leigh syndrome;dyschromatosis symmetrica hereditaria,AD;AR,Definitive;Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q24.2,ADCY10,full=NA,"hypercalciuria, absorptive, 2",AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p21.2,AGL,full=NA,glycogen storage disease III,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11-p35.3,AHDC1,full=NA,AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p35.1,AK2,full=NA,reticular dysgenesis,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.13,ALDH4A1,full=NA,hyperprolinemia type 2,AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p21.3,ALG14,full=NA,congenital myasthenic syndrome 15,AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,ALG6,full=NA,congenital disorder of glycosylation type 1C,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,ALPL,full=NA,adult hypophosphatasia;childhood hypophosphatasia;hypophosphatasia;infantile hypophosphatasia,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,ALX3,full=NA,frontorhiny,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.2,AMPD1,full=NA,myopathy due to myoadenylate deaminase deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p13.3,AMPD2,full=NA,pontocerebellar hypoplasia type 9,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,ANGPTL3,full=NA,familial hypobetalipoproteinemia 2,AR,Moderate,Delly,5'UTR-3'UTR
1,p13.2,AP4B1,full=NA,AP-4 deficiency syndrome;hereditary spastic paraplegia 47,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q42.13,ARF1,full=NA,periventricular nodular heterotopia 8,AD,Definitive,Delly,5'UTR-3'UTR
1,p22.1,ARHGAP29,full=NA,cleft lip with or without cleft palate,AD,Definitive,Delly,5'UTR-3'UTR
1,p36.11,ARID1A,full=NA,"Coffin-Siris syndrome;Coffin-Siris syndrome 1;intellectual disability, autosomal dominant 14",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.1,ARL8A,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q42.2,ARV1,full=NA,"developmental and epileptic encephalopathy, 38",AR,Strong,Delly,5'UTR-3'UTR
1,q22,ASH1L,full=NA,"intellectual disability, autosomal dominant 40;intellectual disability, autosomal dominant 52",AD,Strong,Delly,5'UTR-3'UTR
1,q31.3,ASPM,full=NA,"microcephaly 5, primary, autosomal recessive",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.3,ATF6,full=NA,achromatopsia;achromatopsia 7,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,ATP13A2,full=NA,Kufor-Rakeb syndrome;autosomal recessive spastic paraplegia type 78,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.1,ATP1A1,full=NA,"charcot-marie-tooth disease, axonal, type 2DD;hypomagnesemia, seizures, and intellectual disability 2",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q23.2,ATP1A2,full=NA,"alternating hemiplegia of childhood 1;familial or sporadic hemiplegic migraine;migraine, familial hemiplegic, 2",AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p32.3,BSND,full=NA,Bartter disease type 4a,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,C1QA,full=NA,C1Q deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.12,C1QB,full=NA,C1Q deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.12,C1QC,full=NA,C1Q deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p32.2,C8B,full=NA,type II complement component 8 deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,q25.3,CACNA1E,full=NA,"developmental and epileptic encephalopathy, 69",AD,Strong,Delly,5'UTR-3'UTR
1,q32.1,CACNA1S,full=NA,"congenital myopathy;hypokalemic periodic paralysis, type 1;malignant hyperthermia, susceptibility to, 5",AD;AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.1,CASQ2,full=NA,Hypertrophic cardiomyopathy;catecholaminergic polymorphic ventricular tachycardia;catecholaminergic polymorphic ventricular tachycardia 2,AD;AR,Definitive;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p35.2,CCDC28B,full=NA,Bardet-Biedl syndrome 1,AR,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q24.2,CD247,full=NA,immunodeficiency 25,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.2,CD46,full=NA,atypical hemolytic-uremic syndrome with MCP/CD46 anomaly,AD;sD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p21.2,CDC14A,full=NA,autosomal recessive nonsyndromic deafness 105;autosomal recessive nonsyndromic deafness 32;hearing impairment and infertile male syndrome;nonsyndromic genetic deafness,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.12,CDC42,full=NA,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,q31.2,CDC73,full=NA,hyperparathyroidism-jaw tumor syndrome,AD,Definitive,Delly,5'UTR-3'UTR
1,q41,CENPF,full=NA,Stromme syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,q31.3,CFHR5,full=NA,C3 glomerulonephritis,AD,Strong,Delly,5'UTR-3'UTR
1,q32.1,CHI3L1,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.3,CHRNB2,full=NA,autosomal dominant nocturnal frontal lobe epilepsy 3,AD,Strong,Delly,5'UTR-3'UTR
1,p22.3,CLCA2,full=NA,heart conduction disease,AD,Moderate,Delly,5'UTR-3'UTR
1,p34.2,CLDN19,full=NA,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,COA7,full=NA,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q42.2,COG2,full=NA,"congenital disorder of glycosylation, type IIq",AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p21.1,COL11A1,full=NA,Marshall syndrome;Stickler syndrome type 2;fibrochondrogenesis 1,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p22.3,COL24A1,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.2,COL9A2,full=NA,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q25.3,COLGALT2,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q23.2,COPA,full=NA,autoimmune interstitial lung disease-arthritis syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,q42.13,COQ8A,full=NA,coenzyme Q10 deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,p32.3,CPT2,full=NA,"Carnitine palmitoyltransferase II deficiency;carnitine palmitoyl transferase II deficiency, myopathic form;carnitine palmitoyl transferase II deficiency, neonatal form;carnitine palmitoyl transferase II deficiency, severe infantile form",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.2,CR2,full=NA,"immunodeficiency, common variable, 7",AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,q31.3,CRB1,full=NA,Leber congenital amaurosis 8,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.3,CSF3R,full=NA,autosomal recessive severe congenital neutropenia due to CSF3R deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p31.1,CTH,full=NA,cystathioninuria (disease),AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p34.2,CTPS1,full=NA,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,q21.3,CTSK,full=NA,pycnodysostosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q25.1,DARS2,full=NA,leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p21.2,DBT,full=NA,maple syrup urine disease;maple syrup urine disease type 2,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.3,DCST1,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.12,DDOST,full=NA,DDOST-CDG,AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,q23.3,DDR2,full=NA,spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome;warburg-cinotti syndrome,AD;AR,Definitive;Limited;Moderate,Delly,5'UTR-3'UTR
1,q32.1,DDX59,full=NA,orofaciodigital syndrome V,AR,Strong,Delly,5'UTR-3'UTR
1,q42.11,DEGS1,full=NA,"leukodystrophy, hypomyelinating, 18",AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p32.3,DHCR24,full=NA,desmosterolosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,DNAJC6,full=NA,juvenile onset Parkinson disease 19A,AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p31.3,DOCK7,full=NA,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q22,DPM3,full=NA,DPM3-CDG,AR,Strong,Delly,5'UTR-3'UTR
1,p13.3,DRAM2,full=NA,cone-rod dystrophy 21,AR,Strong,Delly,5'UTR-3'UTR
1,q32.1,DSTYK,full=NA,"congenital anomalies of kidney and urinary tract 1, susceptibility to",AD;AR,Definitive;Limited,Delly,5'UTR-3'UTR
1,p36.12,ECE1,full=NA,"essential hypertension, genetic",NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.2,ECM1,full=NA,lipoid proteinosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q42.2,EGLN1,full=NA,"erythrocytosis, familial, 3",AD,Strong,Delly,5'UTR-3'UTR
1,p34.1,EIF2B3,full=NA,leukoencephalopathy with vanishing white matter,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ELOVL1,full=NA,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.13,EMC1,full=NA,"cerebellar atrophy, visual impairment, and psychomotor retardation;",AR,Moderate,Delly,5'UTR-3'UTR
1,p35.3,EPB41,full=NA,elliptocytosis 1,AR,Strong,Delly,5'UTR-3'UTR
1,q31.3,F13B,full=NA,"factor XIII, b subunit, deficiency of",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.2,F5,full=NA,congenital factor V deficiency;thrombophilia due to activated protein C resistance,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.3,FAM71A,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q24.3,FASLG,full=NA,autoimmune lymphoproliferative syndrome type 1,AR,Moderate,Delly,5'UTR-3'UTR
1,q23.3,FCGR2B,full=NA,systemic lupus erythematosus (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q22,FDPS,full=NA,"porokeratosis 9, multiple types",AD,Strong,Delly,5'UTR-3'UTR
1,q21.3,FLAD1,full=NA,myopathy with abnormal lipid metabolism,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.3,FLG,full=NA,autosomal dominant ichthyosis vulgaris,AD;AR;sD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q21.3,FLG2,full=NA,peeling skin syndrome 6,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.3,FLVCR1,full=NA,posterior column ataxia-retinitis pigmentosa syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.3,FMO3,full=NA,trimethylaminuria (disease),AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p33,FOXE3,full=NA,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.11,FUCA1,full=NA,fucosidosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11,GALE,full=NA,galactose epimerase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q42.13,GALNT2,full=NA,"congenital disorder of glycosylation, type iit",AR,Strong,Delly,5'UTR-3'UTR
1,q21.3,GATAD2B,full=NA,severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,q22,GBA,full=NA,Gaucher disease;Gaucher disease perinatal lethal;Gaucher disease type I;Gaucher disease type II;Gaucher disease type III;Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome;late-onset Parkinson disease,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,GJA5,full=NA,"atrial fibrillation, familial, 11;heart conduction disease",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.3,GJB3,full=NA,autosomal dominant nonsyndromic deafness 2B;erythrokeratodermia variabilis;erythrokeratodermia variabilis et progressiva 1;nonsyndromic genetic deafness,AD;AR,Disputed Evidence;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.3,GJB4,full=NA,erythrokeratodermia variabilis et progressiva 2,AD;AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q42.13,GJC2,full=NA,"hereditary spastic paraplegia 44;hypomyelinating leukodystrophy 2;lymphedema, hereditary, 1C",AD;AR,Definitive,Delly,5'UTR-3'UTR
1,p22.1,GLMN,full=NA,glomuvenous malformation,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q25.3,GLUL,full=NA,congenital brain dysgenesis due to glutamine synthetase deficiency,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.3,GNAI3,full=NA,auriculocondylar syndrome 1,AD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p13.3,GNAT2,full=NA,achromatopsia 4,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q42.2,GNPAT,full=NA,rhizomelic chondrodysplasia punctata;rhizomelic chondrodysplasia punctata type 2,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.2,GORAB,full=NA,geroderma osteodysplastica,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p13.3,GPSM2,full=NA,Chudley-McCullough syndrome,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.11,GRHL3,full=NA,van der Woude syndrome 1;van der Woude syndrome 2,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.3,HAX1,full=NA,Kostmann syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p22.2,HFM1,full=NA,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Disputed Evidence,Delly,5'UTR-3'UTR
1,q32.2,HHAT,full=NA,chondrodysplasia-pseudohermaphroditism syndrome,AR,Moderate,Delly,5'UTR-3'UTR
1,q21.1,HJV,full=NA,hemochromatosis type 2A,AR,Strong,Delly,5'UTR-3'UTR
1,p36.11,HMGCL,full=NA,3-hydroxy-3-methylglutaric aciduria,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,HMGCS2,full=NA,3-hydroxy-3-methylglutaryl-CoA synthase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.12,HNRNPR,full=NA,"intellectual disability, autosomal dominant 40",AD,Definitive,Delly,5'UTR-3'UTR
1,q21.3,HORMAD1,full=NA,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Moderate,Delly,5'UTR-3'UTR
1,p35.1,HPCA,full=NA,torsion dystonia 2,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,HPDL,full=NA,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Delly,5'UTR-3'UTR
1,p12,HSD3B2,full=NA,congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p36.12,HSPG2,full=NA,Silverman-Handmaker type dyssegmental dysplasia,AR,Definitive,Delly,5'UTR-3'UTR
1,q42.13,IBA57,full=NA,multiple mitochondrial dysfunctions syndrome 3,AR,Strong,Delly,5'UTR-3'UTR
1,q23.1,INSRR,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q32.2,IRF6,full=NA,autosomal dominant popliteal pterygium syndrome;van der Woude syndrome 1,AD,Definitive,Delly,5'UTR-3'UTR
1,q42.12,ITPKB,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p13.3,KCNA2,full=NA,infantile epilepsy syndrome;undetermined early-onset epileptic encephalopathy,AD,Strong,Delly,5'UTR-3'UTR
1,p13.2,KCND3,full=NA,Brugada syndrome 1;Brugada syndrome 9;spinocerebellar ataxia type 19/22,AD,Disputed Evidence;Limited;Strong,Delly,5'UTR-3'UTR
1,q32.2,KCNH1,full=NA,Temple-Baraitser syndrome;Zimmermann-Laband syndrome 1,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.2,KCNJ10,full=NA,EAST syndrome;enlarged vestibular aqueduct syndrome,AD;AR,Definitive;Disputed Evidence;Strong,Delly,5'UTR-3'UTR
1,p34.2,KCNQ4,full=NA,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q31.3,KCNT2,full=NA,"developmental and epileptic encephalopathy, 57",AD,Moderate,Delly,5'UTR-3'UTR
1,p36.12,KDM1A,full=NA,palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q32.1,KDM5B,full=NA,Tourette syndrome;autism susceptibility 1,AD,No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,q32.1,KIF14,full=NA,lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome,AR,Moderate,Delly,5'UTR-3'UTR
1,p36.12,KIF17,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q32.2,LAMB3,full=NA,"amelogenesis imperfecta type 1A;junctional epidermolysis bullosa;junctional epidermolysis bullosa Herlitz type;junctional epidermolysis bullosa, non-Herlitz type",AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q25.3,LAMC2,full=NA,"junctional epidermolysis bullosa;junctional epidermolysis bullosa Herlitz type;junctional epidermolysis bullosa, non-Herlitz type",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q42.12,LBR,full=NA,Greenberg dysplasia;Pelger-Huet anomaly;regressive spondylometaphyseal dysplasia,AD;AR,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p36.11,LDLRAP1,full=NA,"hypercholesterolemia, familial, 4",AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,LEPR,full=NA,obesity due to leptin receptor gene deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,q25.2,LHX4,full=NA,short stature-pituitary and cerebellar defects-small sella turcica syndrome,AD,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q22,LMNA,full=NA,"Charcot-Marie-Tooth disease type 2B1;Emery-Dreifuss muscular dystrophy 2, autosomal dominant;Hutchinson-Gilford progeria syndrome;Primary dilated cardiomyopathy;arrhythmogenic right ventricular cardiomyopathy;atrioventricular block (disease);dilated cardiomyopathy 1A;familial partial lipodystrophy, Dunnigan type;heart-hand syndrome, Slovenian type",AD;AR;sD,Definitive;Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,LMX1A,full=NA,autosomal dominant nonsyndromic deafness 7,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,q21.3,LORICRIN,full=NA,keratoderma hereditarium mutilans with ichthyosis,AD,Strong,Delly,5'UTR-3'UTR
1,p13.2,LRIG2,full=NA,urofacial syndrome 2;urofacial syndrome type 1,AR,Strong,Delly,5'UTR-3'UTR
1,p32.3,LRP8,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.3,MACF1,full=NA,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p35.3,MECR,full=NA,"Leigh syndrome;dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,MFSD2A,full=NA,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,MMACHC,full=NA,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,MPL,full=NA,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,MPZ,full=NA,Charcot-Marie-Tooth disease;Charcot-Marie-Tooth disease type 1B,AD,Definitive,Delly,5'UTR-3'UTR
1,q22,MSTO1,full=NA,mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,AR,Moderate,Delly,5'UTR-3'UTR
1,q22,MUC1,full=NA,medullary cystic kidney disease 1,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.1,MUTYH,full=NA,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,q24.3,MYOC,full=NA,"glaucoma 1, open angle, A;glaucoma 3A",AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q25.3,NCF2,full=NA,"granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.2,NCSTN,full=NA,"acne inversa, familial, 1",AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,NDUFS2,full=NA,"Leigh syndrome;mitochondrial complex 1 deficiency, nuclear type 6",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.3,NECTIN4,full=NA,ectodermal dysplasia-syndactyly syndrome 1,AR,Moderate,Delly,5'UTR-3'UTR
1,p31.1,NEXN,full=NA,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;hypertrophic cardiomyopathy 20,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q32.1,NFASC,full=NA,neurodevelopmental disorder with central and peripheral motor dysfunction,AD;AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p31.3,NFIA,full=NA,chromosome 1p32-p31 deletion syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,p12,NOTCH2,full=NA,Alagille syndrome;acroosteolysis dominant type,AD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,q25.2,NPHS2,full=NA,"nephrotic syndrome, type 2",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p36.11,NR0B2,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p13.2,NRAS,full=NA,Costello syndrome;Noonan syndrome;Noonan syndrome 6;Noonan syndrome with multiple lentigines;cardiofaciocutaneous syndrome,AD,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,q23.1,NTRK1,full=NA,hereditary sensory and autonomic neuropathy type 4,AR,Definitive,Delly,5'UTR-3'UTR
1,q42.13,NUP133,full=NA,Galloway-Mowat syndrome 8,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p32.3,ORC1,full=NA,Meier-Gorlin syndrome 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,P3H1,full=NA,osteogenesis imperfecta type 8,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,PADI3,full=NA,uncombable hair syndrome 1,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p32.3,PARS2,full=NA,"developmental and epileptic encephalopathy, 75",AR,Moderate,Delly,5'UTR-3'UTR
1,p36.13,PAX7,full=NA,"congenital myopathy with myasthenic-like onset;myopathy, congenital, progressive, with scoliosis",AR,Moderate,Delly,5'UTR-3'UTR
1,q23.3,PBX1,full=NA,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",AD,Strong,Delly,5'UTR-3'UTR
1,p32.3,PCSK9,full=NA,"hypercholesterolemia, autosomal dominant, 3",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.1,PEX11B,full=NA,peroxisome biogenesis disorder;peroxisome biogenesis disorder 14B,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.2,PEX19,full=NA,peroxisome biogenesis disorder;peroxisome biogenesis disorder 12A (Zellweger);peroxisome biogenesis disorder 1A (Zellweger),AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,PGM1,full=NA,PGM1-CDG,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p12,PHGDH,full=NA,PHGDH deficiency;neurometabolic disorder due to serine deficiency,AR,Definitive,Delly,5'UTR-3'UTR
1,q24.3,PIGC,full=NA,glycosylphosphatidylinositol biosynthesis defect 16,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p31.1,PIGK,full=NA,"neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.2,PIGM,full=NA,hypercoagulability syndrome due to glycosylphosphatidylinositol deficiency,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p36.11,PIGV,full=NA,hyperphosphatasia with intellectual disability syndrome 1,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p36.12,PINK1,full=NA,autosomal recessive early-onset Parkinson disease 6,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q22,PKLR,full=NA,pyruvate kinase deficiency of red cells;pyruvate kinase hyperactivity,AD;AR,Definitive;Limited,Delly,5'UTR-3'UTR
1,q32.1,PKP1,full=NA,epidermolysis bullosa simplex due to plakophilin deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p36.13,PLA2G2A,full=NA,colorectal cancer,AD,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q31.1,PLA2G4A,full=NA,cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q32.1,PLEKHA6,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.3,PMVK,full=NA,POROK1,AD,Moderate,Delly,5'UTR-3'UTR
1,q21.3,POGZ,full=NA,"intellectual disability, autosomal dominant 40;intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,POMGNT1,full=NA,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.2,PPCS,full=NA,"cardiomyopathy, dilated, 2c",AR,Moderate,Delly,5'UTR-3'UTR
1,q23.3,PPOX,full=NA,variegate porphyria,AD;AR,Strong,Delly,5'UTR-3'UTR
1,q32.1,PPP1R15B,full=NA,"microcephaly, short stature, and impaired glucose metabolism 2",AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,PPT1,full=NA,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q31.1,PRG4,full=NA,camptodactyly-arthropathy-coxa vara-pericarditis syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,PRPF3,full=NA,retinitis pigmentosa 18,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.3,PRUNE1,full=NA,"neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies",AR,Strong,Delly,5'UTR-3'UTR
1,q42.13,PSEN2,full=NA,Alzheimer disease 4;Primary dilated cardiomyopathy,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p34.1,PTCH2,full=NA,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q41-q32.3,PTPN14,full=NA,lymphedema-posterior choanal atresia syndrome,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.1-q31.3,PTPRC,full=NA,"severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-positive, NK cell-positive",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Delly,5'UTR-3'UTR
1,q41,RAB3GAP2,full=NA,cataract-intellectual disability-hypogonadism syndrome,AR,Definitive,Delly,5'UTR-3'UTR
1,q21.1,RBM8A,full=NA,thrombocytopenia-absent radius syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.3,RD3,full=NA,Leber congenital amaurosis 12,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q23.3,RGS5,full=NA,"essential hypertension, genetic",NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q22,RIT1,full=NA,Noonan syndrome;Noonan syndrome 8,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,ROR1,full=NA,"deafness, autosomal recessive 108;nonsyndromic genetic deafness",AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,q21.3,RORC,full=NA,autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,p31.3,RPE65,full=NA,Leber congenital amaurosis 9,AR,Definitive,Delly,5'UTR-3'UTR
1,p36.11,RPL11,full=NA,Diamond-Blackfan anemia 7,AD,Strong,Delly,5'UTR-3'UTR
1,p22.1,RPL5,full=NA,Diamond-Blackfan anemia 6,AD,Strong,Delly,5'UTR-3'UTR
1,p34.3,RSPO1,full=NA,palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p21.2,SASS6,full=NA,"microcephaly 14, primary, autosomal recessive",AR,Moderate,Delly,5'UTR-3'UTR
1,p36.13,SDHB,full=NA,Carney-Stratakis syndrome;gastrointestinal stromal tumor;hereditary pheochromocytoma-paraganglioma;paragangliomas 4;renal cell carcinoma (disease),AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q23.3,SDHC,full=NA,Carney-Stratakis syndrome;gastrointestinal stromal tumor;hereditary pheochromocytoma-paraganglioma;paragangliomas 3;renal cell carcinoma (disease),AD,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q21.3,SELENBP1,full=NA,extraoral halitosis due to methanethiol oxidase deficiency;schizophrenia (disease),AR,Limited;No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.11,SELENON,full=NA,SELENON-related myopathy,AR,Definitive,Delly,5'UTR-3'UTR
1,q25.1,SERPINC1,full=NA,antithrombin III deficiency,AD;AR;sD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q21.2,SF3B4,full=NA,Nager acrofacial dysostosis,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.2,SLC16A1,full=NA,ketoacidosis due to monocarboxylate transporter-1 deficiency,sD,Moderate,Delly,5'UTR-3'UTR
1,q24.2,SLC19A2,full=NA,thiamine-responsive megaloblastic anemia syndrome,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,SLC25A24,full=NA,"progeroid syndrome, Petty type",AD,Strong,Delly,5'UTR-3'UTR
1,p34.2,SLC2A1,full=NA,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q41,SLC30A10,full=NA,cirrhosis - dystonia - polycythemia - hypermanganesemia syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p21.2,SLC35A3,full=NA,autism spectrum disorder - epilepsy - arthrogryposis syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,SLC35D1,full=NA,schneckenbecken dysplasia,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.3,SLC6A17,full=NA,progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome;schizophrenia (disease),AR,No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p34.1,SLC6A9,full=NA,atypical glycine encephalopathy,AR,Strong,Delly,5'UTR-3'UTR
1,p36.11,SLC9A1,full=NA,Lichtenstein-Knorr syndrome,AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,q32.1,SNRPE,full=NA,hypotrichosis 11,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p12,SPAG17,full=NA,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Moderate,Delly,5'UTR-3'UTR
1,q23.1,SPTA1,full=NA,elliptocytosis 2;hereditary spherocytosis type 3,AD;AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p33,STIL,full=NA,"microcephaly 7, primary, autosomal recessive",AR,Strong,Delly,5'UTR-3'UTR
1,q32.1,SYT2,full=NA,congenital myasthenic syndrome 7,AD;AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p32.1,TACSTD2,full=NA,gelatinous drop-like corneal dystrophy,AR,Strong,Delly,5'UTR-3'UTR
1,p12,TBX15,full=NA,pelviscapular dysplasia,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q24.2,TBX19,full=NA,congenital isolated adrenocorticotropic hormone deficiency (disease),AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q41,TGFB2,full=NA,Loeys-Dietz syndrome 4;familial thoracic aortic aneurysm and aortic dissection,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,q22,THBS3,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q24.1,TMCO1,full=NA,cerebrofaciothoracic dysplasia,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,q42.12,TMEM63A,full=NA,"leukodystrophy, hypomyelinating, 19, transient infantile",AD,Strong,Delly,5'UTR-3'UTR
1,p31.1,TNNI3K,full=NA,Primary dilated cardiomyopathy;atrial conduction disease,AD,Limited;Strong,Delly,5'UTR-3'UTR
1,q32.1,TNNT2,full=NA,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;arrhythmogenic right ventricular cardiomyopathy;dilated cardiomyopathy 1D;hypertrophic cardiomyopathy 2,AD,Definitive;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p34.1,TOE1,full=NA,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,q25.2,TOR1AIP1,full=NA,autosomal recessive limb-girdle muscular dystrophy type 2Y,AR,Moderate,Delly,5'UTR-3'UTR
1,q41,TP53BP2,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q21.3,TPM3,full=NA,TPM3-related myopathy;congenital fiber-type disproportion myopathy;nemaline myopathy 1,sD,Definitive;Moderate,Delly,5'UTR-3'UTR
1,p34.2,TRIT1,full=NA,combined oxidative phosphorylation deficiency 35,AR,Strong,Delly,5'UTR-3'UTR
1,q25.3,TSEN15,full=NA,"pontocerebellar hypoplasia, type 2F",AR,Strong,Delly,5'UTR-3'UTR
1,p13.2,TSHB,full=NA,isolated thyroid-stimulating hormone deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,q32.1,UBE2T,full=NA,Fanconi anemia complementation group T,AR,Strong,Delly,5'UTR-3'UTR
1,q23.3,UFC1,full=NA,neurodevelopmental disorder with spasticity and poor growth,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,UROD,full=NA,familial porphyria cutanea tarda,AD;AR,Strong,Delly,5'UTR-3'UTR
1,q41,USH2A,full=NA,Usher syndrome type 2;Usher syndrome type 2A,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,USP1,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p36.12,USP48,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,q23.2,VANGL2,full=NA,"neural tube defects, susceptibility to",AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,q42.12-q42.11,WDR26,full=NA,Skraban-Deardorff syndrome,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p13.2,WNT2B,full=NA,diarrhea 9,AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p36.12,WNT4,full=NA,SERKAL syndrome;mullerian aplasia and hyperandrogenism,AD;AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,q25.3,XPR1,full=NA,"basal ganglia calcification, idiopathic, 6",AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p35.1,YARS1,full=NA,Charcot-Marie-Tooth disease,AD,Definitive,Delly,5'UTR-3'UTR
1,q22,YY1AP1,full=NA,grange syndrome,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=NA,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p31.3,ALG6,full=NA,congenital disorder of glycosylation type 1C,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,ANGPTL3,full=NA,familial hypobetalipoproteinemia 2,AR,Moderate,Delly,5'UTR-3'UTR
1,p32.3,BSND,full=NA,Bartter disease type 4a,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.2,C8B,full=NA,type II complement component 8 deficiency,AR,Moderate,Delly,5'UTR-3'UTR
1,p34.2,CLDN19,full=NA,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,COA7,full=NA,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,COL9A2,full=NA,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p32.3,CPT2,full=NA,"Carnitine palmitoyltransferase II deficiency;carnitine palmitoyl transferase II deficiency, myopathic form;carnitine palmitoyl transferase II deficiency, neonatal form;carnitine palmitoyl transferase II deficiency, severe infantile form",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.3,CSF3R,full=NA,autosomal recessive severe congenital neutropenia due to CSF3R deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,CTPS1,full=NA,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p32.3,DHCR24,full=NA,desmosterolosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,DOCK7,full=NA,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.1,EIF2B3,full=NA,leukoencephalopathy with vanishing white matter,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ELOVL1,full=NA,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p33,FOXE3,full=NA,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.3,GJB3,full=NA,autosomal dominant nonsyndromic deafness 2B;erythrokeratodermia variabilis;erythrokeratodermia variabilis et progressiva 1;nonsyndromic genetic deafness,AD;AR,Disputed Evidence;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.3,GJB4,full=NA,erythrokeratodermia variabilis et progressiva 2,AD;AR,Limited;Strong,Delly,5'UTR-3'UTR
1,p34.1,HPDL,full=NA,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Delly,5'UTR-3'UTR
1,p34.2,KCNQ4,full=NA,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,LRP8,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.3,MACF1,full=NA,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,MFSD2A,full=NA,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,MMACHC,full=NA,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,MPL,full=NA,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.1,MUTYH,full=NA,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p31.3,NFIA,full=NA,chromosome 1p32-p31 deletion syndrome,AD,Strong,Delly,5'UTR-3'UTR
1,p32.3,ORC1,full=NA,Meier-Gorlin syndrome 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,P3H1,full=NA,osteogenesis imperfecta type 8,AR,Strong,Delly,5'UTR-3'UTR
1,p32.3,PARS2,full=NA,"developmental and epileptic encephalopathy, 75",AR,Moderate,Delly,5'UTR-3'UTR
1,p32.3,PCSK9,full=NA,"hypercholesterolemia, autosomal dominant, 3",AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p31.3,PGM1,full=NA,PGM1-CDG,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,POMGNT1,full=NA,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.2,PPCS,full=NA,"cardiomyopathy, dilated, 2c",AR,Moderate,Delly,5'UTR-3'UTR
1,p34.2,PPT1,full=NA,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,PTCH2,full=NA,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,ROR1,full=NA,"deafness, autosomal recessive 108;nonsyndromic genetic deafness",AR,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.3,RSPO1,full=NA,palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,SLC2A1,full=NA,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,SLC6A9,full=NA,atypical glycine encephalopathy,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p33,STIL,full=NA,"microcephaly 7, primary, autosomal recessive",AR,Strong,Delly,5'UTR-3'UTR
1,p32.1,TACSTD2,full=NA,gelatinous drop-like corneal dystrophy,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,TOE1,full=NA,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,TRIT1,full=NA,combined oxidative phosphorylation deficiency 35,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,UROD,full=NA,familial porphyria cutanea tarda,AD;AR,Strong,Delly,5'UTR-3'UTR
1,p31.3,USP1,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=NA,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,CLDN19,full=NA,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,COA7,full=NA,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3",AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,COL9A2,full=NA,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p32.3,CPT2,full=NA,"Carnitine palmitoyltransferase II deficiency;carnitine palmitoyl transferase II deficiency, myopathic form;carnitine palmitoyl transferase II deficiency, neonatal form;carnitine palmitoyl transferase II deficiency, severe infantile form",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.3,CSF3R,full=NA,autosomal recessive severe congenital neutropenia due to CSF3R deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,CTPS1,full=NA,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,EIF2B3,full=NA,leukoencephalopathy with vanishing white matter,AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ELOVL1,full=NA,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Delly,5'UTR-3'UTR
1,p33,FOXE3,full=NA,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.1,HPDL,full=NA,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Delly,5'UTR-3'UTR
1,p34.2,KCNQ4,full=NA,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p32.3,LRP8,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
1,p34.3,MACF1,full=NA,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,MFSD2A,full=NA,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,MMACHC,full=NA,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,MPL,full=NA,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.1,MUTYH,full=NA,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Delly,5'UTR-3'UTR
1,p32.3,ORC1,full=NA,Meier-Gorlin syndrome 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.2,P3H1,full=NA,osteogenesis imperfecta type 8,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,POMGNT1,full=NA,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
1,p34.2,PPCS,full=NA,"cardiomyopathy, dilated, 2c",AR,Moderate,Delly,5'UTR-3'UTR
1,p34.2,PPT1,full=NA,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,PTCH2,full=NA,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Delly,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Delly,5'UTR-3'UTR
1,p34.3,RSPO1,full=NA,palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,SLC2A1,full=NA,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Delly,5'UTR-3'UTR
1,p34.1,SLC6A9,full=NA,atypical glycine encephalopathy,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Delly,5'UTR-3'UTR
1,p33,STIL,full=NA,"microcephaly 7, primary, autosomal recessive",AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,TOE1,full=NA,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,TRIT1,full=NA,combined oxidative phosphorylation deficiency 35,AR,Strong,Delly,5'UTR-3'UTR
1,p34.1,UROD,full=NA,familial porphyria cutanea tarda,AD;AR,Strong,Delly,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=NA,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Delly,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Delly,CDS
15,q24.3-q24.2,ETFA,full=NA,multiple acyl-CoA dehydrogenase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
15,q24.3,PSTPIP1,full=NA,pyogenic arthritis-pyoderma gangrenosum-acne syndrome,AD,Strong,Delly,5'UTR-3'UTR
15,q24.2,SIN3A,full=NA,"autism, susceptibility to, 15;chromosome 15q24 deletion syndrome",AD,Strong,Delly,5'UTR-3'UTR
20,q13.12,ADA,full=NA,adenosine deaminase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
20,q13.12,CTSA,full=NA,galactosialidosis,AR,Definitive;Strong,Delly,5'UTR-3'UTR
20,q13.12,FITM2,full=NA,siddiqi syndrome,AR,Strong,Delly,5'UTR-3'UTR
20,q13.12,HNF4A,full=NA,"Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young;diabetes mellitus, noninsulin-dependent;maturity-onset diabetes of the young type 1;monogenic diabetes",AD,Definitive;Strong,Delly,5'UTR-3'UTR
20,q13.12,JPH2,full=NA,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;hypertrophic cardiomyopathy 17,AD;sD,Moderate,Delly,5'UTR-3'UTR
20,q12,MAFB,full=NA,multicentric carpo-tarsal osteolysis with or without nephropathy,AD,Definitive;Moderate,Delly,5'UTR-3'UTR
20,q13.12,PIGT,full=NA,multiple congenital anomalies-hypotonia-seizures syndrome 3,AR,Definitive;Strong,Delly,5'UTR-3'UTR
20,q13.12,SLC2A10,full=NA,arterial tortuosity syndrome;familial thoracic aortic aneurysm and aortic dissection,AD;AR,Definitive;Limited;Strong,Delly,5'UTR-3'UTR
20,q11.23,SRC,full=NA,colorectal cancer,NA,No Known Disease Relationship,Delly,5'UTR-3'UTR
20,q13.12,TNNC2,full=NA,Hypertrophic cardiomyopathy,AD,No Known Disease Relationship,Delly,5'UTR-3'UTR
20,q13.12,TP53RK,full=NA,Galloway-Mowat syndrome 4,AR,Strong,Delly,5'UTR-3'UTR
20,q13.12,ZNF335,full=NA,microcephalic primordial dwarfism due to ZNF335 deficiency,AR,Strong,Delly,5'UTR-3'UTR
20,q13.12,ADA,full=NA,adenosine deaminase deficiency,AR,Definitive;Strong,Delly,5'UTR-3'UTR
20,q13.12,FITM2,full=NA,siddiqi syndrome,AR,Strong,Delly,5'UTR-3'UTR
20,q13.12,HNF4A,full=NA,"Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young;diabetes mellitus, noninsulin-dependent;maturity-onset diabetes of the young type 1;monogenic diabetes",AD,Definitive;Strong,Delly,5'UTR-3'UTR
20,q13.12,JPH2,full=NA,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;hypertrophic cardiomyopathy 17,AD;sD,Moderate,Delly,5'UTR-3'UTR
20,q12,MAFB,full=NA,multicentric carpo-tarsal osteolysis with or without nephropathy,AD,Definitive;Moderate,Delly,5'UTR-3'UTR
20,q13.33,EEF1A2,full=3,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 33",AD,Definitive;Moderate,Manta,CDS
20,p12.3,MCM8,full=1,premature ovarian failure 10,AR,Moderate;Strong,Manta,CDS
20,p12.3,PLCB1,full=1,"developmental and epileptic encephalopathy, 12",AR,Definitive;Moderate;Strong,Manta,CDS
20,q11.21,KIF3B,full=1,ciliopathy;retinitis pigmentosa 89,AD,Limited;Moderate,Manta,CDS
20,p11.21,SYNDIG1,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Manta,CDS
1,p36.31,NPHP4,full=NA,nephronophthisis 4,AR,Definitive,Melt,CDS
10,q21.1,PCDH15,full=NA,Usher syndrome type 1;Usher syndrome type 1F;autosomal recessive nonsyndromic deafness 23;nonsyndromic genetic deafness,AR,Definitive;Limited;Strong,Melt,CDS
12,q12,ARID2,full=NA,Coffin-Siris syndrome,AD,Strong,Melt,CDS
2,p15,WDPCP,full=NA,Bardet-Biedl syndrome 15;heart defect - tongue hamartoma - polysyndactyly syndrome,AR,Definitive;Limited,Melt,CDS
20,p12.3,PLCB1,full=NA,"developmental and epileptic encephalopathy, 12",AR,Definitive;Moderate;Strong,Melt,CDS
20,p12.3,PLCB1,full=NA,"developmental and epileptic encephalopathy, 12",AR,Definitive;Moderate;Strong,Melt,CDS
4,q21.21,FRAS1,full=NA,Fraser syndrome 1,AR,Definitive,Melt,CDS
5,q13.2,ARHGEF28,full=NA,amyotrophic lateral sclerosis,AD;AR,Moderate,Melt,CDS
8,q13.3,EYA1,full=NA,branchio-oto-renal syndrome;branchiootic syndrome 1;branchiootorenal syndrome 1;otofaciocervical syndrome 1,AD,Definitive;Limited;Strong,Melt,CDS
1,p35.2,CCDC28B,full=3,Bardet-Biedl syndrome 1,AR,No Known Disease Relationship,Wham,5'UTR-3'UTR
1,p36.23,CAMTA1,full=3,nonprogressive cerebellar atxia with mental retardation,AD,Strong,Wham,CDS
1,p34.3,MACF1,full=3,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Wham,CDS
20,p12.3,PLCB1,full=3,"developmental and epileptic encephalopathy, 12",AR,Definitive;Moderate;Strong,Wham,CDS
20,q11.21,KIF3B,full=3,ciliopathy;retinitis pigmentosa 89,AD,Limited;Moderate,Wham,CDS
20,q13.33,COL9A3,full=3,"Stickler syndrome;epiphyseal dysplasia, multiple, 3",AD;AR,Definitive;Moderate;Strong,Wham,CDS
20,q13.33,EEF1A2,full=3,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 33",AD,Definitive;Moderate,Wham,CDS
1,p36.22,VPS13D,full=NA,Leigh syndrome;autosomal recessive cerebellar ataxia-saccadic intrusion syndrome,AR,Limited;Strong,Wham,CDS
1,p35.1,AK2,full=NA,reticular dysgenesis,AR,Definitive,Wham,5'UTR-3'UTR
1,p35.2,CCDC28B,full=NA,Bardet-Biedl syndrome 1,AR,No Known Disease Relationship,Wham,5'UTR-3'UTR
1,p34.2,CLDN19,full=NA,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,COL9A2,full=NA,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
1,p34.3,CSF3R,full=NA,autosomal recessive severe congenital neutropenia due to CSF3R deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,CTPS1,full=NA,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,EIF2B3,full=NA,leukoencephalopathy with vanishing white matter,AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,ELOVL1,full=NA,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Wham,5'UTR-3'UTR
1,p33,FOXE3,full=NA,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.3,GJB3,full=NA,autosomal dominant nonsyndromic deafness 2B;erythrokeratodermia variabilis;erythrokeratodermia variabilis et progressiva 1;nonsyndromic genetic deafness,AD;AR,Disputed Evidence;Limited;Strong,Wham,5'UTR-3'UTR
1,p34.3,GJB4,full=NA,erythrokeratodermia variabilis et progressiva 2,AD;AR,Limited;Strong,Wham,5'UTR-3'UTR
1,p35.1,HPCA,full=NA,torsion dystonia 2,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,HPDL,full=NA,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,KCNQ4,full=NA,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.3,MACF1,full=NA,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,MFSD2A,full=NA,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,MMACHC,full=NA,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,MPL,full=NA,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,MUTYH,full=NA,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Wham,5'UTR-3'UTR
1,p34.2,P3H1,full=NA,osteogenesis imperfecta type 8,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,POMGNT1,full=NA,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
1,p34.2,PPCS,full=NA,"cardiomyopathy, dilated, 2c",AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,PPT1,full=NA,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,PTCH2,full=NA,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Wham,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Wham,5'UTR-3'UTR
1,p34.3,RSPO1,full=NA,palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,SLC2A1,full=NA,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,SLC6A9,full=NA,atypical glycine encephalopathy,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Wham,5'UTR-3'UTR
1,p33,STIL,full=NA,"microcephaly 7, primary, autosomal recessive",AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,TOE1,full=NA,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,TRIT1,full=NA,combined oxidative phosphorylation deficiency 35,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,UROD,full=NA,familial porphyria cutanea tarda,AD;AR,Strong,Wham,5'UTR-3'UTR
1,p35.1,YARS1,full=NA,Charcot-Marie-Tooth disease,AD,Definitive,Wham,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=NA,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p31.3,ALG6,full=NA,congenital disorder of glycosylation type 1C,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,ANGPTL3,full=NA,familial hypobetalipoproteinemia 2,AR,Moderate,Wham,5'UTR-3'UTR
1,p32.3,BSND,full=NA,Bartter disease type 4a,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p32.2,C8B,full=NA,type II complement component 8 deficiency,AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,CLDN19,full=NA,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p32.3,COA7,full=NA,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3",AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,COL9A2,full=NA,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
1,p32.3,CPT2,full=NA,"Carnitine palmitoyltransferase II deficiency;carnitine palmitoyl transferase II deficiency, myopathic form;carnitine palmitoyl transferase II deficiency, neonatal form;carnitine palmitoyl transferase II deficiency, severe infantile form",AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.3,CSF3R,full=NA,autosomal recessive severe congenital neutropenia due to CSF3R deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,CTPS1,full=NA,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p32.3,DHCR24,full=NA,desmosterolosis,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,DOCK7,full=NA,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,EIF2B3,full=NA,leukoencephalopathy with vanishing white matter,AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,ELOVL1,full=NA,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Wham,5'UTR-3'UTR
1,p33,FOXE3,full=NA,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.3,GJB3,full=NA,autosomal dominant nonsyndromic deafness 2B;erythrokeratodermia variabilis;erythrokeratodermia variabilis et progressiva 1;nonsyndromic genetic deafness,AD;AR,Disputed Evidence;Limited;Strong,Wham,5'UTR-3'UTR
1,p34.3,GJB4,full=NA,erythrokeratodermia variabilis et progressiva 2,AD;AR,Limited;Strong,Wham,5'UTR-3'UTR
1,p34.1,HPDL,full=NA,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,KCNQ4,full=NA,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p32.3,LRP8,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
1,p34.3,MACF1,full=NA,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,MFSD2A,full=NA,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,MMACHC,full=NA,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,MPL,full=NA,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,MUTYH,full=NA,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Wham,5'UTR-3'UTR
1,p31.3,NFIA,full=NA,chromosome 1p32-p31 deletion syndrome,AD,Strong,Wham,5'UTR-3'UTR
1,p32.3,ORC1,full=NA,Meier-Gorlin syndrome 1,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,P3H1,full=NA,osteogenesis imperfecta type 8,AR,Strong,Wham,5'UTR-3'UTR
1,p32.3,PARS2,full=NA,"developmental and epileptic encephalopathy, 75",AR,Moderate,Wham,5'UTR-3'UTR
1,p32.3,PCSK9,full=NA,"hypercholesterolemia, autosomal dominant, 3",AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,PGM1,full=NA,PGM1-CDG,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,POMGNT1,full=NA,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
1,p34.2,PPCS,full=NA,"cardiomyopathy, dilated, 2c",AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,PPT1,full=NA,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,PTCH2,full=NA,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Wham,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Wham,5'UTR-3'UTR
1,p31.3,ROR1,full=NA,"deafness, autosomal recessive 108;nonsyndromic genetic deafness",AR,Limited;Moderate,Wham,5'UTR-3'UTR
1,p34.3,RSPO1,full=NA,palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,SLC2A1,full=NA,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,SLC6A9,full=NA,atypical glycine encephalopathy,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Wham,5'UTR-3'UTR
1,p33,STIL,full=NA,"microcephaly 7, primary, autosomal recessive",AR,Strong,Wham,5'UTR-3'UTR
1,p32.1,TACSTD2,full=NA,gelatinous drop-like corneal dystrophy,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,TOE1,full=NA,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,TRIT1,full=NA,combined oxidative phosphorylation deficiency 35,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,UROD,full=NA,familial porphyria cutanea tarda,AD;AR,Strong,Wham,5'UTR-3'UTR
1,p31.3,USP1,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=NA,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,CLDN19,full=NA,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p32.3,COA7,full=NA,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3",AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,COL9A2,full=NA,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
1,p32.3,CPT2,full=NA,"Carnitine palmitoyltransferase II deficiency;carnitine palmitoyl transferase II deficiency, myopathic form;carnitine palmitoyl transferase II deficiency, neonatal form;carnitine palmitoyl transferase II deficiency, severe infantile form",AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.3,CSF3R,full=NA,autosomal recessive severe congenital neutropenia due to CSF3R deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,CTPS1,full=NA,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,EIF2B3,full=NA,leukoencephalopathy with vanishing white matter,AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,ELOVL1,full=NA,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Wham,5'UTR-3'UTR
1,p33,FOXE3,full=NA,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,HPDL,full=NA,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,KCNQ4,full=NA,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p32.3,LRP8,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
1,p34.3,MACF1,full=NA,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,MFSD2A,full=NA,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,MMACHC,full=NA,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,MPL,full=NA,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,MUTYH,full=NA,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Wham,5'UTR-3'UTR
1,p32.3,ORC1,full=NA,Meier-Gorlin syndrome 1,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,P3H1,full=NA,osteogenesis imperfecta type 8,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,POMGNT1,full=NA,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
1,p34.2,PPCS,full=NA,"cardiomyopathy, dilated, 2c",AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,PPT1,full=NA,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,PTCH2,full=NA,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Wham,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Wham,5'UTR-3'UTR
1,p34.3,RSPO1,full=NA,palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome,AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,SLC2A1,full=NA,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,SLC6A9,full=NA,atypical glycine encephalopathy,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Wham,5'UTR-3'UTR
1,p33,STIL,full=NA,"microcephaly 7, primary, autosomal recessive",AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,TOE1,full=NA,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,TRIT1,full=NA,combined oxidative phosphorylation deficiency 35,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,UROD,full=NA,familial porphyria cutanea tarda,AD;AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=NA,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,CLDN19,full=NA,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,COL9A2,full=NA,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
1,p34.2,CTPS1,full=NA,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,EIF2B3,full=NA,leukoencephalopathy with vanishing white matter,AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,ELOVL1,full=NA,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Wham,5'UTR-3'UTR
1,p34.2,KCNQ4,full=NA,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.3,MACF1,full=NA,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,MFSD2A,full=NA,"microcephaly 15, primary, autosomal recessive",AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,MPL,full=NA,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,P3H1,full=NA,osteogenesis imperfecta type 8,AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,PPCS,full=NA,"cardiomyopathy, dilated, 2c",AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,PPT1,full=NA,neuronal ceroid lipofuscinosis 1,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,PTCH2,full=NA,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Wham,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,SLC2A1,full=NA,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,SLC6A9,full=NA,atypical glycine encephalopathy,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,TRIT1,full=NA,combined oxidative phosphorylation deficiency 35,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,UROD,full=NA,familial porphyria cutanea tarda,AD;AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=NA,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p31.1,ACADM,full=NA,medium chain acyl-CoA dehydrogenase deficiency,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,ALG6,full=NA,congenital disorder of glycosylation type 1C,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,ANGPTL3,full=NA,familial hypobetalipoproteinemia 2,AR,Moderate,Wham,5'UTR-3'UTR
1,p32.3,BSND,full=NA,Bartter disease type 4a,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p32.2,C8B,full=NA,type II complement component 8 deficiency,AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,CLDN19,full=NA,renal hypomagnesemia 5 with ocular involvement,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p32.3,COA7,full=NA,"spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3",AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.2,COL9A2,full=NA,"Stickler syndrome;Stickler syndrome, type 5;epiphyseal dysplasia, multiple, 2",AD;AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
1,p32.3,CPT2,full=NA,"Carnitine palmitoyltransferase II deficiency;carnitine palmitoyl transferase II deficiency, myopathic form;carnitine palmitoyl transferase II deficiency, neonatal form;carnitine palmitoyl transferase II deficiency, severe infantile form",AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.1,CTH,full=NA,cystathioninuria (disease),AR,Definitive;Moderate,Wham,5'UTR-3'UTR
1,p34.2,CTPS1,full=NA,severe combined immunodeficiency due to CTPS1 deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p32.3,DHCR24,full=NA,desmosterolosis,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,DNAJC6,full=NA,juvenile onset Parkinson disease 19A,AR,Limited;Moderate;Strong,Wham,5'UTR-3'UTR
1,p31.3,DOCK7,full=NA,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,EIF2B3,full=NA,leukoencephalopathy with vanishing white matter,AR,Strong,Wham,5'UTR-3'UTR
1,p34.2,ELOVL1,full=NA,"ichthyotic keratoderma, spasticity, hypomyelination, and dysmorphic facial features",AD,Limited;Strong,Wham,5'UTR-3'UTR
1,p33,FOXE3,full=NA,"anterior segment dysgenesis 1;aortic aneurysm, familial thoracic 11, susceptibility to;congenital primary aphakia;familial thoracic aortic aneurysm and aortic dissection",AD;AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,HPDL,full=NA,Leigh syndrome;neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,AR,Moderate,Wham,5'UTR-3'UTR
1,p34.2,KCNQ4,full=NA,autosomal dominant nonsyndromic deafness 2A;nonsyndromic genetic deafness,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,LEPR,full=NA,obesity due to leptin receptor gene deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p32.3,LRP8,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
1,p34.1,MMACHC,full=NA,methylmalonic aciduria and homocystinuria type cblC,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,MPL,full=NA,congenital amegakaryocytic thrombocytopenia;thrombocythemia 2,AD;AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,MUTYH,full=NA,MUTYH-related attenuated familial adenomatous polyposis;familial ovarian cancer;hereditary breast carcinoma,AD;AR,Definitive;Limited;Moderate;No Known Disease Relationship;Strong,Wham,5'UTR-3'UTR
1,p31.1,NEXN,full=NA,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;hypertrophic cardiomyopathy 20,AD,Limited;Moderate,Wham,5'UTR-3'UTR
1,p31.3,NFIA,full=NA,chromosome 1p32-p31 deletion syndrome,AD,Strong,Wham,5'UTR-3'UTR
1,p32.3,ORC1,full=NA,Meier-Gorlin syndrome 1,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.2,P3H1,full=NA,osteogenesis imperfecta type 8,AR,Strong,Wham,5'UTR-3'UTR
1,p32.3,PARS2,full=NA,"developmental and epileptic encephalopathy, 75",AR,Moderate,Wham,5'UTR-3'UTR
1,p32.3,PCSK9,full=NA,"hypercholesterolemia, autosomal dominant, 3",AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,PGM1,full=NA,PGM1-CDG,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.1,PIGK,full=NA,"neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures",AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,POMGNT1,full=NA,"autosomal recessive limb-girdle muscular dystrophy type 2O;muscle-eye-brain disease;muscular dystrophy-dystroglycanopathy;muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3;muscular dystrophy-dystroglycanopathy (congenital with mental retardation), type B3;retinitis pigmentosa 76",AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
1,p34.2,PPCS,full=NA,"cardiomyopathy, dilated, 2c",AR,Moderate,Wham,5'UTR-3'UTR
1,p34.1,PTCH2,full=NA,nevoid basal cell carcinoma syndrome,AD,Limited;Moderate,Wham,5'UTR-3'UTR
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Wham,5'UTR-3'UTR
1,p31.3,ROR1,full=NA,"deafness, autosomal recessive 108;nonsyndromic genetic deafness",AR,Limited;Moderate,Wham,5'UTR-3'UTR
1,p31.3,RPE65,full=NA,Leber congenital amaurosis 9,AR,Definitive,Wham,5'UTR-3'UTR
1,p34.2,SLC2A1,full=NA,GLUT1 deficiency syndrome;childhood onset GLUT1 deficiency syndrome 2;dystonia 9;encephalopathy due to GLUT1 deficiency,AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,SLC35D1,full=NA,schneckenbecken dysplasia,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p34.1,SLC6A9,full=NA,atypical glycine encephalopathy,AR,Strong,Wham,5'UTR-3'UTR
1,p34.1,ST3GAL3,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 15;intellectual disability, autosomal recessive 12",AR,Limited;Moderate;Strong,Wham,5'UTR-3'UTR
1,p33,STIL,full=NA,"microcephaly 7, primary, autosomal recessive",AR,Strong,Wham,5'UTR-3'UTR
1,p32.1,TACSTD2,full=NA,gelatinous drop-like corneal dystrophy,AR,Strong,Wham,5'UTR-3'UTR
1,p31.1,TNNI3K,full=NA,Primary dilated cardiomyopathy;atrial conduction disease,AD,Limited;Strong,Wham,5'UTR-3'UTR
1,p34.1,TOE1,full=NA,pontocerebellar hypoplasia type 7,AR,Moderate;Strong,Wham,5'UTR-3'UTR
1,p34.1,UROD,full=NA,familial porphyria cutanea tarda,AD;AR,Strong,Wham,5'UTR-3'UTR
1,p31.3,USP1,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
1,p34.2,ZMPSTE24,full=NA,lethal restrictive dermopathy;mandibuloacral dysplasia with type B lipodystrophy,AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p31.3,ALG6,full=NA,congenital disorder of glycosylation type 1C,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,ANGPTL3,full=NA,familial hypobetalipoproteinemia 2,AR,Moderate,Wham,5'UTR-3'UTR
1,p32.3,BSND,full=NA,Bartter disease type 4a,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p32.2,C8B,full=NA,type II complement component 8 deficiency,AR,Moderate,Wham,5'UTR-3'UTR
1,p32.3,DHCR24,full=NA,desmosterolosis,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,DNAJC6,full=NA,juvenile onset Parkinson disease 19A,AR,Limited;Moderate;Strong,Wham,5'UTR-3'UTR
1,p31.3,DOCK7,full=NA,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
1,p31.3,LEPR,full=NA,obesity due to leptin receptor gene deficiency,AR,Strong,Wham,5'UTR-3'UTR
1,p31.3,NFIA,full=NA,chromosome 1p32-p31 deletion syndrome,AD,Strong,Wham,5'UTR-3'UTR
1,p32.3,PARS2,full=NA,"developmental and epileptic encephalopathy, 75",AR,Moderate,Wham,5'UTR-3'UTR
1,p32.3,PCSK9,full=NA,"hypercholesterolemia, autosomal dominant, 3",AD,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,PGM1,full=NA,PGM1-CDG,AR,Definitive;Strong,Wham,5'UTR-3'UTR
1,p31.3,ROR1,full=NA,"deafness, autosomal recessive 108;nonsyndromic genetic deafness",AR,Limited;Moderate,Wham,5'UTR-3'UTR
1,p32.1,TACSTD2,full=NA,gelatinous drop-like corneal dystrophy,AR,Strong,Wham,5'UTR-3'UTR
1,p31.3,USP1,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
1,p32.2,C8B,full=NA,type II complement component 8 deficiency,AR,Moderate,Wham,5'UTR-3'UTR
1,p32.1,TACSTD2,full=NA,gelatinous drop-like corneal dystrophy,AR,Strong,Wham,5'UTR-3'UTR
20,q13.12,ADA,full=NA,adenosine deaminase deficiency,AR,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.13,ADNP,full=NA,ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder,AD,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.13,ARFGEF2,full=NA,"periventricular heterotopia with microcephaly, autosomal recessive",AR,Strong,Wham,5'UTR-3'UTR
20,q13.12,CTSA,full=NA,galactosialidosis,AR,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.2,CYP24A1,full=NA,autosomal recessive infantile hypercalcemia 1,AR,Strong,Wham,5'UTR-3'UTR
20,q13.13,DPM1,full=NA,SRD5A3-CDG;congenital disorder of glycosylation type 1E,AR,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.12,FITM2,full=NA,siddiqi syndrome,AR,Strong,Wham,5'UTR-3'UTR
20,q13.12,HNF4A,full=NA,"Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young;diabetes mellitus, noninsulin-dependent;maturity-onset diabetes of the young type 1;monogenic diabetes",AD,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.12,JPH2,full=NA,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;hypertrophic cardiomyopathy 17,AD;sD,Moderate,Wham,5'UTR-3'UTR
20,q13.13,KCNB1,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 26",AD,Definitive;Strong,Wham,5'UTR-3'UTR
20,q12,MAFB,full=NA,multicentric carpo-tarsal osteolysis with or without nephropathy,AD,Definitive;Moderate,Wham,5'UTR-3'UTR
20,q13.12,PIGT,full=NA,multiple congenital anomalies-hypotonia-seizures syndrome 3,AR,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.2,SALL4,full=NA,Duane-radial ray syndrome,AD,Definitive;Strong,Wham,5'UTR-3'UTR
20,q11.23,SAMHD1,full=NA,Aicardi-Goutieres syndrome 5;Moyamoya disease;chilblain lupus,AD;AR,Disputed Evidence;Strong,Wham,5'UTR-3'UTR
20,q13.12,SLC2A10,full=NA,arterial tortuosity syndrome;familial thoracic aortic aneurysm and aortic dissection,AD;AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
20,q11.23,SRC,full=NA,colorectal cancer,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
20,q13.32,STX16,full=NA,pseudohypoparathyroidism type 1B,AD,Strong,Wham,5'UTR-3'UTR
20,q13.12,TNNC2,full=NA,Hypertrophic cardiomyopathy,AD,No Known Disease Relationship,Wham,5'UTR-3'UTR
20,q13.12,TP53RK,full=NA,Galloway-Mowat syndrome 4,AR,Strong,Wham,5'UTR-3'UTR
20,q13.32,VAPB,full=NA,amyotrophic lateral sclerosis type 8,AD,Strong,Wham,5'UTR-3'UTR
20,q13.12,ZNF335,full=NA,microcephalic primordial dwarfism due to ZNF335 deficiency,AR,Strong,Wham,5'UTR-3'UTR
20,q13.12,ADA,full=NA,adenosine deaminase deficiency,AR,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.13,ARFGEF2,full=NA,"periventricular heterotopia with microcephaly, autosomal recessive",AR,Strong,Wham,5'UTR-3'UTR
20,q13.12,CTSA,full=NA,galactosialidosis,AR,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.12,FITM2,full=NA,siddiqi syndrome,AR,Strong,Wham,5'UTR-3'UTR
20,q13.12,HNF4A,full=NA,"Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young;diabetes mellitus, noninsulin-dependent;maturity-onset diabetes of the young type 1;monogenic diabetes",AD,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.12,JPH2,full=NA,Hypertrophic cardiomyopathy;Primary dilated cardiomyopathy;hypertrophic cardiomyopathy 17,AD;sD,Moderate,Wham,5'UTR-3'UTR
20,q13.13,KCNB1,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 26",AD,Definitive;Strong,Wham,5'UTR-3'UTR
20,q12,MAFB,full=NA,multicentric carpo-tarsal osteolysis with or without nephropathy,AD,Definitive;Moderate,Wham,5'UTR-3'UTR
20,q13.12,PIGT,full=NA,multiple congenital anomalies-hypotonia-seizures syndrome 3,AR,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.12,SLC2A10,full=NA,arterial tortuosity syndrome;familial thoracic aortic aneurysm and aortic dissection,AD;AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
20,q13.12,TNNC2,full=NA,Hypertrophic cardiomyopathy,AD,No Known Disease Relationship,Wham,5'UTR-3'UTR
20,q13.12,TP53RK,full=NA,Galloway-Mowat syndrome 4,AR,Strong,Wham,5'UTR-3'UTR
20,q13.12,ZNF335,full=NA,microcephalic primordial dwarfism due to ZNF335 deficiency,AR,Strong,Wham,5'UTR-3'UTR
20,q13.13,ADNP,full=NA,ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder,AD,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.2,CYP24A1,full=NA,autosomal recessive infantile hypercalcemia 1,AR,Strong,Wham,5'UTR-3'UTR
20,q13.13,DPM1,full=NA,SRD5A3-CDG;congenital disorder of glycosylation type 1E,AR,Definitive;Strong,Wham,5'UTR-3'UTR
20,q13.2,SALL4,full=NA,Duane-radial ray syndrome,AD,Definitive;Strong,Wham,5'UTR-3'UTR
21,q21.3,APP,full=NA,"Alzheimer disease type 1;cerebral amyloid angiopathy, APP-related",AD,Strong,Wham,CDS
4,q34.3,AGA,full=NA,aspartylglucosaminuria,AR,Definitive;Strong,Wham,5'UTR-3'UTR
4,q34.1,HPGD,full=NA,"hypertrophic osteoarthropathy, primary, autosomal recessive, 1",AR,Definitive;Strong,Wham,5'UTR-3'UTR
4,q33,NEK1,full=NA,"amyotrophic lateral sclerosis, susceptibility to, 24;short-rib thoracic dysplasia 6 with or without polydactyly",AD;AR,Definitive;Moderate,Wham,5'UTR-3'UTR
4,q34.3,VEGFC,full=NA,"lymphedema, hereditary, 1D",AD,Strong,Wham,5'UTR-3'UTR
7,q31.32,AASS,full=NA,hyperlysinemia (disease),AR,Moderate;Strong,Wham,5'UTR-3'UTR
7,q21.12,ABCB4,full=NA,low phospholipid associated cholelithiasis,sD,Definitive,Wham,5'UTR-3'UTR
7,q22.1,ACTL6B,full=NA,"developmental and epileptic encephalopathy, 76;intellectual developmental disorder with severe speech and ambulation defects",AD;AR,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
7,q21.12,ADAM22,full=NA,"developmental and epileptic encephalopathy, 61",AR,Moderate,Wham,5'UTR-3'UTR
7,q21.2,AKAP9,full=NA,long QT syndrome;long QT syndrome 11;male infertility with azoospermia or oligozoospermia due to single gene mutation,AD;AR,Disputed Evidence;Limited;Moderate,Wham,5'UTR-3'UTR
7,q22.1,AP1S1,full=NA,MEDNIK syndrome,AR,Strong,Wham,5'UTR-3'UTR
7,q22.1,AP4M1,full=NA,AP-4 deficiency syndrome;hereditary spastic paraplegia 50,AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
7,q22.1,ARPC1B,full=NA,platelet abnormalities with eosinophilia and immune-mediated inflammatory disease,AR,Definitive;Strong,Wham,5'UTR-3'UTR
7,q11.21,ASL,full=NA,argininosuccinic aciduria,AR,Definitive;Strong,Wham,5'UTR-3'UTR
7,q21.3,ASNS,full=NA,congenital microcephaly - severe encephalopathy - progressive cerebral atrophy syndrome,AR,Definitive;Strong,Wham,5'UTR-3'UTR
7,q31.2,ASZ1,full=NA,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Moderate,Wham,5'UTR-3'UTR
7,q11.22,AUTS2,full=NA,"Syndromic intellectual disability;autism spectrum disorder due to AUTS2 deficiency;autism, susceptibility to, 15",AD,Definitive;Strong,Wham,5'UTR-3'UTR
7,q21.11,CACNA2D1,full=NA,Brugada syndrome;Brugada syndrome 1;short QT syndrome,AD,Disputed Evidence;Limited,Wham,5'UTR-3'UTR
7,q21.3,CALCR,full=NA,osteoporosis,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
7,q31.2,CAV1,full=NA,"congenital generalized lipodystrophy type 3;pulmonary hypertension, primary, 3",AD;AR,Limited;Moderate,Wham,5'UTR-3'UTR
7,q11.23,CCDC146,full=NA,male infertility with azoospermia or oligozoospermia due to single gene mutation,AR,Moderate,Wham,5'UTR-3'UTR
7,q21.11,CD36,full=NA,platelet-type bleeding disorder 10,AR,Strong,Wham,5'UTR-3'UTR
7,q31.2,CFTR,full=NA,cystic fibrosis;hereditary chronic pancreatitis,AD;AR,Definitive;Limited,Wham,5'UTR-3'UTR
7,q22.3,COG5,full=NA,COG5-CDG,AR,Strong,Wham,5'UTR-3'UTR
7,q21.3,COL1A2,full=NA,"Ehlers-Danlos syndrome, cardiac valvular type;ehlers-danlos syndrome, arthrochalasia type, 2",AD;AR,Strong,Wham,5'UTR-3'UTR
7,q22.1,CUX1,full=NA,global developmental delay with or without impaired intellectual development,AD,Moderate;Strong,Wham,5'UTR-3'UTR
7,q31.1,DLD,full=NA,Leigh syndrome;maple syrup urine disease;pyruvate dehydrogenase E3 deficiency,AR,Definitive;Strong,Wham,5'UTR-3'UTR
7,q11.23,ELN,full=NA,"cutis laxa, autosomal dominant 1;supravalvular aortic stenosis (disease)",AD,Definitive;Strong,Wham,5'UTR-3'UTR
7,q22.1,EPHB4,full=NA,"capillary malformation-arteriovenous malformation 2;hydrops fetalis, nonimmune, and/or atrial septal defect, susceptibility to",AD,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
7,q22.1,EPO,full=NA,"erythrocytosis, familial, 5",AD,Strong,Wham,5'UTR-3'UTR
7,q31.32,FEZF1,full=NA,hypogonadotropic hypogonadism 22 with or without anosmia,AR,Moderate;Strong,Wham,5'UTR-3'UTR
7,q32.1,FLNC,full=NA,Primary dilated cardiomyopathy;heart conduction disease;hypertrophic cardiomyopathy 26;myofibrillar myopathy 5,AD,Definitive;Limited;Strong,Wham,5'UTR-3'UTR
7,q31.1,FOXP2,full=NA,childhood apraxia of speech;specific language disorder,AD,Definitive;Strong,Wham,5'UTR-3'UTR
7,q21.11,GNAI1,full=NA,complex neurodevelopmental disorder,AD,Definitive,Wham,5'UTR-3'UTR
7,q11.21,GUSB,full=NA,mucopolysaccharidosis type 7,AR,Definitive;Strong,Wham,5'UTR-3'UTR
7,q21.2,HEPACAM2,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
7,q21.11,HGF,full=NA,autosomal recessive nonsyndromic deafness 39;nonsyndromic genetic deafness,AR,Limited;Moderate;Strong,Wham,5'UTR-3'UTR
7,q11.23,HSPB1,full=NA,"neuronopathy, distal hereditary motor, type 2B",AD,Moderate,Wham,5'UTR-3'UTR
7,q32.1,IMPDH1,full=NA,retinitis pigmentosa 10,AD,Moderate,Wham,5'UTR-3'UTR
7,q11.21,KCTD7,full=NA,progressive myoclonic epilepsy type 3;progressive myoclonus epilepsy,AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
7,q22.3,KMT2E,full=NA,"O'Donnell-Luria-Rodan syndrome;intellectual disability, autosomal dominant 40",AD,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
7,q21.2,KRIT1,full=NA,familial cerebral cavernous malformation 1,AD,Definitive;Strong,Wham,5'UTR-3'UTR
7,q31.1,LAMB1,full=NA,cobblestone lissencephaly without muscular or ocular involvement,AR,Moderate;Strong,Wham,5'UTR-3'UTR
7,q32.1,LEP,full=NA,obesity due to congenital leptin deficiency,AR,Strong,Wham,5'UTR-3'UTR
7,q21.11,MAGI2,full=NA,infantile epilepsy syndrome;nephrotic syndrome 15,AR;XL,Disputed Evidence;Limited,Wham,5'UTR-3'UTR
7,q11.23,MDH2,full=NA,"developmental and epileptic encephalopathy, 51",AR,Moderate,Wham,5'UTR-3'UTR
7,q31.2,MET,full=NA,autosomal recessive nonsyndromic deafness 97;nonsyndromic genetic deafness;osteofibrous dysplasia;papillary renal cell carcinoma,AD;AR,Definitive;Limited;Moderate;Strong,Wham,5'UTR-3'UTR
7,q11.23,NCF1,full=NA,"granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 1",AR,Strong,Wham,5'UTR-3'UTR
7,q32.1,PAX4,full=NA,"diabetes mellitus, noninsulin-dependent;monogenic diabetes",AD,Limited;Refuted Evidence,Wham,5'UTR-3'UTR
7,q21.11,PCLO,full=NA,pontocerebellar hypoplasia type 3,AR,Moderate,Wham,5'UTR-3'UTR
7,q21.2,PEX1,full=NA,Heimler syndrome 1;peroxisome biogenesis disorder;peroxisome biogenesis disorder 1A (Zellweger);peroxisome biogenesis disorder 1B,AR,Definitive;Moderate;Strong,Wham,5'UTR-3'UTR
7,q22.1,PLOD3,full=NA,connective tissue disorder due to lysyl hydroxylase-3 deficiency,AR,Limited;Moderate;Strong,Wham,5'UTR-3'UTR
7,q22.1,PMPCB,full=NA,multiple mitochondrial dysfunctions syndrome 6,AR,Moderate;Strong,Wham,5'UTR-3'UTR
7,q31.1,PNPLA8,full=NA,mitochondrial myopathy-lactic acidosis-deafness syndrome,AR,Moderate,Wham,5'UTR-3'UTR
7,q11.23,POM121C,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
7,q11.23,POR,full=NA,Antley-Bixler syndrome with genital anomalies and disordered steroidogenesis,AR,Strong,Wham,5'UTR-3'UTR
7,q31.1,PPP1R3A,full=NA,"diabetes mellitus, noninsulin-dependent",NA,Limited;No Known Disease Relationship,Wham,5'UTR-3'UTR
7,q22.3,PUS7,full=NA,"intellectual developmental disorder with abnormal behavior, microcephaly, and short stature",AR,Moderate,Wham,5'UTR-3'UTR
7,q22.1,RELN,full=NA,Norman-Roberts syndrome;complex neurodevelopmental disorder,AD;AR,Definitive;Disputed Evidence;Strong,Wham,5'UTR-3'UTR
7,q22.3,RINT1,full=NA,familial ovarian cancer;hereditary breast carcinoma,AD,Disputed Evidence;No Known Disease Relationship,Wham,5'UTR-3'UTR
7,q21.12,RUNDC3B,full=NA,schizophrenia (disease),NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
7,q21.2,SAMD9,full=NA,MIRAGE syndrome;normophosphatemic familial tumoral calcinosis,AD;AR,Definitive;Moderate,Wham,5'UTR-3'UTR
7,q21.2,SAMD9L,full=NA,ataxia-pancytopenia syndrome,AD,Limited;Strong,Wham,5'UTR-3'UTR
7,q11.21,SBDS,full=NA,Shwachman-Diamond syndrome;Shwachman-Diamond syndrome 1,AR,Definitive;Strong,Wham,5'UTR-3'UTR
7,q22.1,SERPINE1,full=NA,congenital plasminogen activator inhibitor type 1 deficiency,AR,Strong,Wham,5'UTR-3'UTR
7,q21.3,SGCE,full=NA,myoclonic dystonia 11,AD,Strong,Wham,5'UTR-3'UTR
7,q21.3,SLC25A13,full=NA,citrin deficiency,AR,Definitive,Wham,5'UTR-3'UTR
7,q31.1-q22.3,SLC26A3,full=NA,congenital secretory chloride diarrhea 1,AR,Strong,Wham,5'UTR-3'UTR
7,q22.3,SLC26A4,full=NA,Pendred syndrome;autosomal recessive nonsyndromic deafness 4,AR,Definitive;Strong,Wham,5'UTR-3'UTR
7,q22.1,SLC26A5,full=NA,autosomal recessive nonsyndromic deafness 61;nonsyndromic genetic deafness,AR,Limited;Strong,Wham,5'UTR-3'UTR
7,q32.1,SMO,full=NA,curry-Jones syndrome,AD;SOM,Definitive;Strong,Wham,5'UTR-3'UTR
7,q32.1,STRIP2,full=NA,Tourette syndrome,NA,No Known Disease Relationship,Wham,5'UTR-3'UTR
7,q22.1,TFR2,full=NA,hemochromatosis type 3,AR,Strong,Wham,5'UTR-3'UTR
7,q32.1,TNPO3,full=NA,autosomal dominant limb-girdle muscular dystrophy;autosomal dominant limb-girdle muscular dystrophy type 1F,AD,Limited;Strong,Wham,5'UTR-3'UTR
7,q31.31,TSPAN12,full=NA,exudative vitreoretinopathy 5,AD,Strong,Wham,5'UTR-3'UTR
7,q11.23,ZP3,full=NA,oocyte maturation defect 3,AD,Strong,Wham,5'UTR-3'UTR
1,p32.3,DHCR24,full=1,desmosterolosis,AR,Definitive;Strong,Svaba,CDS
1,p34.3,MACF1,full=NA,lissencephaly 9 with complex brainstem malformation,AD,Moderate;Strong,Svaba,CDS
1,p36.23,CAMTA1,full=NA,nonprogressive cerebellar atxia with mental retardation,AD,Strong,Svaba,CDS
1,p36.23,CAMTA1,full=NA,nonprogressive cerebellar atxia with mental retardation,AD,Strong,Svaba,CDS
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Svaba,CDS
1,p34.2,PTPRF,full=NA,"breasts and/or nipples, aplasia or hypoplasia of, 2",AR,Strong,Svaba,CDS
1,p31.3,DOCK7,full=NA,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Svaba,CDS
1,p31.3,DOCK7,full=NA,"developmental and epileptic encephalopathy;developmental and epileptic encephalopathy, 23",AR,Definitive;Moderate;Strong,Svaba,CDS
20,p12.3,MCM8,full=NA,premature ovarian failure 10,AR,Moderate;Strong,Svaba,CDS
20,p12.3,MCM8,full=NA,premature ovarian failure 10,AR,Moderate;Strong,Svaba,CDS
20,p12.3,PLCB1,full=NA,"developmental and epileptic encephalopathy, 12",AR,Definitive;Moderate;Strong,Svaba,CDS
20,p12.3,PLCB1,full=NA,"developmental and epileptic encephalopathy, 12",AR,Definitive;Moderate;Strong,Svaba,CDS
20,p11.23,KIZ,full=NA,retinitis pigmentosa 69,AR,Strong,Svaba,CDS
20,p11.23,KIZ,full=NA,retinitis pigmentosa 69,AR,Strong,Svaba,CDS
20,q13.33,EEF1A2,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 33",AD,Definitive;Moderate,Svaba,CDS
20,q13.33,EEF1A2,full=NA,"complex neurodevelopmental disorder;developmental and epileptic encephalopathy, 33",AD,Definitive;Moderate,Svaba,CDS
